| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 2.70e-08 | 130 | 180 | 11 | GO:0005200 | |
| GeneOntologyMolecularFunction | structural molecule activity | KRT72 VIM KRT10 MYH11 H3-5 ANK2 KRT17 ANK3 KRT18 COPB1 DSP KRT27 NUP98 LAMA5 LAMB2 ODF2 GFAP NEFH NEFL LMNA MACF1 PLEC CROCC MUC5AC KRT25 | 4.62e-07 | 891 | 180 | 25 | GO:0005198 |
| GeneOntologyMolecularFunction | protein kinase A binding | 1.75e-04 | 58 | 180 | 5 | GO:0051018 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic intermediate filament cytoskeleton | 2.41e-04 | 3 | 180 | 2 | GO:0099184 | |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | KRT72 VIM KRT10 KRT17 KRT18 DSP KRT27 GFAP NEFH ATXN3L NEFL MACF1 PLEC KRT25 | 1.41e-13 | 99 | 177 | 14 | GO:0045104 |
| GeneOntologyBiologicalProcess | intermediate filament-based process | KRT72 VIM KRT10 KRT17 KRT18 DSP KRT27 GFAP NEFH ATXN3L NEFL MACF1 PLEC KRT25 | 1.63e-13 | 100 | 177 | 14 | GO:0045103 |
| GeneOntologyBiologicalProcess | intermediate filament organization | 4.14e-11 | 75 | 177 | 11 | GO:0045109 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | CDC42BPA ANK3 RSPH4A STAG1 NDE1 MAP6 SMC1A TTLL5 CNTRL CHD3 ODF2 LRRC43 CCDC57 TBCB NEFH ATXN3L NEFL MISP LMNA CEP20 CEP250 CGN CFAP74 CROCC | 1.34e-08 | 720 | 177 | 24 | GO:0000226 |
| GeneOntologyBiologicalProcess | microtubule-based process | CDC42BPA ANK3 RSPH4A STAG1 NDE1 MAP6 SMC1A TTLL5 CNTRL CHD3 ODF2 LRRC43 CCDC57 CCDC38 TBCB NEFH ATXN3L NEFL MISP LMNA CEP20 CEP250 CGN MACF1 CFAP74 RABGEF1 CROCC DYNC1I2 DNAH11 | 2.79e-08 | 1058 | 177 | 29 | GO:0007017 |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | KRT72 VIM KRT10 MYH10 MYH11 WAS KRT17 NDE1 DSP KRT27 ARFGEF1 CCDC57 GFAP TBCB NEFH NEFL VIPAS39 ARRB1 ACTL8 MYH16 CGNL1 PLEC KRT25 | 7.98e-06 | 957 | 177 | 23 | GO:0097435 |
| GeneOntologyBiologicalProcess | cell projection assembly | RABEP2 MYH10 WAS RSPH4A TTLL5 CNTRL LAMA5 ITGA6 ODF2 LRRC43 CCDC57 CCDC38 NEFH CEP20 CEP250 ARL13B CFAP74 CROCC | 2.61e-05 | 685 | 177 | 18 | GO:0030031 |
| GeneOntologyBiologicalProcess | cilium assembly | RABEP2 RSPH4A TTLL5 CNTRL LAMA5 ODF2 LRRC43 CCDC57 CCDC38 CEP20 CEP250 ARL13B CFAP74 CROCC | 3.09e-05 | 444 | 177 | 14 | GO:0060271 |
| GeneOntologyBiologicalProcess | axonogenesis | VIM NPR2 MYH10 ANK3 MAP6 NTRK1 LAMA5 LAMB2 NEFH NEFL ARHGEF40 NR2E1 ROBO1 MACF1 ROBO3 FLOT1 | 3.14e-05 | 566 | 177 | 16 | GO:0007409 |
| GeneOntologyBiologicalProcess | organelle assembly | RABEP2 MYH10 MYH11 RSPH4A STAG1 SMC1A TTLL5 CNTRL LAMA5 ODF2 LRRC43 CCDC57 CCDC38 MISP VIPAS39 ACTL8 CEP20 JMJD6 CEP250 ARL13B CFAP74 PLEC LRBA CROCC | 4.23e-05 | 1138 | 177 | 24 | GO:0070925 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | TANC2 VIM NPR2 MYH10 NYAP2 ANK3 MAP6 NTRK1 LAMA5 LAMB2 NEFH NEFL ARHGEF40 NR2E1 ROBO1 MACF1 EIF2AK4 ROBO3 FLOT1 | 6.28e-05 | 802 | 177 | 19 | GO:0048812 |
| GeneOntologyBiologicalProcess | cilium organization | RABEP2 RSPH4A TTLL5 CNTRL LAMA5 ODF2 LRRC43 CCDC57 CCDC38 CEP20 CEP250 ARL13B CFAP74 CROCC | 6.55e-05 | 476 | 177 | 14 | GO:0044782 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | RABEP2 MYH10 WAS RSPH4A TTLL5 CNTRL LAMA5 ITGA6 ODF2 LRRC43 CCDC57 CCDC38 CEP20 CEP250 ARL13B CFAP74 CROCC | 6.80e-05 | 670 | 177 | 17 | GO:0120031 |
| GeneOntologyBiologicalProcess | microtubule-based transport | ANK3 RSPH4A NDE1 MAP6 CCDC38 NEFH NEFL RABGEF1 DYNC1I2 DNAH11 | 6.91e-05 | 253 | 177 | 10 | GO:0099111 |
| GeneOntologyBiologicalProcess | protein localization to cell periphery | ANK2 ANK3 KRT18 NSF RAPGEF4 SNAP23 LAMA5 NBEA MISP ARL13B SLMAP MACF1 FLOT1 | 7.55e-05 | 422 | 177 | 13 | GO:1990778 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | TANC2 VIM NPR2 MYH10 NYAP2 ANK3 MAP6 NTRK1 LAMA5 LAMB2 NEFH NEFL ARHGEF40 NR2E1 ROBO1 MACF1 EIF2AK4 ROBO3 FLOT1 | 8.28e-05 | 819 | 177 | 19 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | TANC2 VIM NPR2 MYH10 NYAP2 ANK3 MAP6 NTRK1 LAMA5 LAMB2 NEFH NEFL ARHGEF40 NR2E1 ROBO1 MACF1 EIF2AK4 ROBO3 FLOT1 | 9.26e-05 | 826 | 177 | 19 | GO:0048858 |
| GeneOntologyBiologicalProcess | cell junction organization | TANC2 MYH10 ANK2 ANK3 DSP NTRK1 RAPGEF4 LAMA5 ITGA6 LAMB2 NBEA ACE NEFH NEFL GRHL1 CGN ROBO1 MACF1 PLEC FLOT1 CDH6 | 9.74e-05 | 974 | 177 | 21 | GO:0034330 |
| GeneOntologyBiologicalProcess | skeletal myofibril assembly | 9.75e-05 | 11 | 177 | 3 | GO:0014866 | |
| GeneOntologyBiologicalProcess | neuron projection development | TANC2 VIM NPR2 MYH10 NYAP2 ANK3 MAP6 NTRK1 RAPGEF4 ARFGEF1 LAMA5 ITGA6 LAMB2 GFAP NEFH NEFL ARHGEF40 NR2E1 UBA6 ROBO1 MACF1 EIF2AK4 ROBO3 FLOT1 DYNC1I2 | 1.06e-04 | 1285 | 177 | 25 | GO:0031175 |
| GeneOntologyBiologicalProcess | axon development | VIM NPR2 MYH10 ANK3 MAP6 NTRK1 LAMA5 LAMB2 NEFH NEFL ARHGEF40 NR2E1 ROBO1 MACF1 ROBO3 FLOT1 | 1.38e-04 | 642 | 177 | 16 | GO:0061564 |
| GeneOntologyBiologicalProcess | cytoskeleton-dependent intracellular transport | 1.46e-04 | 225 | 177 | 9 | GO:0030705 | |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | STARD8 CDC42BPA DOCK8 NTRK1 ARFGEF1 ARHGEF40 ARRB1 ROBO1 RABGEF1 CGNL1 FLOT1 | 1.49e-04 | 333 | 177 | 11 | GO:0051056 |
| GeneOntologyBiologicalProcess | Golgi vesicle transport | ANK3 KRT18 COPB1 NSF TMED5 SNAP23 NAPG NBEA TMED3 SEC24C MACF1 | 1.74e-04 | 339 | 177 | 11 | GO:0048193 |
| GeneOntologyBiologicalProcess | postsynaptic intermediate filament cytoskeleton organization | 2.18e-04 | 3 | 177 | 2 | GO:0099185 | |
| GeneOntologyBiologicalProcess | neurofilament bundle assembly | 2.18e-04 | 3 | 177 | 2 | GO:0033693 | |
| GeneOntologyBiologicalProcess | endomembrane system organization | MYH10 ANK2 ANK3 NSF TMED5 SNAP23 ARFGEF1 ATP6V1F CCDC38 PRX TMED3 LMNA PEX5 PLEC FLOT1 GOLGB1 | 2.31e-04 | 672 | 177 | 16 | GO:0010256 |
| GeneOntologyBiologicalProcess | cell morphogenesis | TANC2 VIM NPR2 MYH10 NYAP2 ANK3 MAP6 NTRK1 LAMA5 LAMB2 NEFH NEFL ARHGEF40 CGN NR2E1 ARL13B ROBO1 MACF1 EIF2AK4 PLEC ROBO3 FLOT1 CDH6 | 2.36e-04 | 1194 | 177 | 23 | GO:0000902 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | TANC2 VIM NPR2 MYH10 ANK3 MAP6 NTRK1 LAMA5 LAMB2 NEFH NEFL ARHGEF40 NR2E1 ROBO1 MACF1 ROBO3 FLOT1 | 2.53e-04 | 748 | 177 | 17 | GO:0048667 |
| GeneOntologyBiologicalProcess | centriole-centriole cohesion | 2.62e-04 | 15 | 177 | 3 | GO:0010457 | |
| GeneOntologyBiologicalProcess | transport along microtubule | 3.09e-04 | 197 | 177 | 8 | GO:0010970 | |
| GeneOntologyBiologicalProcess | action potential | 3.54e-04 | 201 | 177 | 8 | GO:0001508 | |
| GeneOntologyBiologicalProcess | keratinocyte development | 3.87e-04 | 17 | 177 | 3 | GO:0003334 | |
| GeneOntologyBiologicalProcess | skin development | KRT72 KRT10 KRT17 DSP KRT27 EXPH5 LAMA5 ITGA6 GRHL1 PLEC KRT25 | 3.93e-04 | 373 | 177 | 11 | GO:0043588 |
| GeneOntologyBiologicalProcess | cellular anatomical entity morphogenesis | 4.05e-04 | 156 | 177 | 7 | GO:0032989 | |
| GeneOntologyBiologicalProcess | cellular component assembly involved in morphogenesis | 4.05e-04 | 156 | 177 | 7 | GO:0010927 | |
| GeneOntologyBiologicalProcess | GCN2-mediated signaling | 4.34e-04 | 4 | 177 | 2 | GO:0140469 | |
| GeneOntologyBiologicalProcess | intracellular transport | TANC2 MYH10 CDC42BPA WAS ANK3 COPB1 NDE1 MAP6 NSF EXPH5 TMED5 NUP98 NAPG NDFIP2 CCDC38 GFAP TMED3 NEFH NEFL VIPAS39 SEC24C LMNA PEX5 RABGEF1 LRBA DYNC1I2 | 4.49e-04 | 1496 | 177 | 26 | GO:0046907 |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle cell contraction | 4.98e-04 | 43 | 177 | 4 | GO:0086004 | |
| GeneOntologyBiologicalProcess | post-Golgi vesicle-mediated transport | 5.71e-04 | 119 | 177 | 6 | GO:0006892 | |
| GeneOntologyBiologicalProcess | Golgi to plasma membrane protein transport | 5.93e-04 | 45 | 177 | 4 | GO:0043001 | |
| GeneOntologyBiologicalProcess | epidermis development | KRT72 KRT10 WAS KRT17 DSP KRT27 EXPH5 LAMA5 GRHL1 SATB1 PLEC KRT25 | 6.55e-04 | 461 | 177 | 12 | GO:0008544 |
| GeneOntologyCellularComponent | supramolecular fiber | KRT72 VIM KRT10 MYH10 MYH11 WAS ANK2 KRT17 ANK3 KRT18 NDE1 MAP6 DSP KRT27 MYH7B TTLL5 ODF2 CCDC57 GFAP TBCB NEFH NEFL MISP ACTL8 LMNA SLMAP MACF1 MYBPHL PLEC KRT25 DYNC1I2 DNAH11 | 6.71e-09 | 1179 | 180 | 32 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | KRT72 VIM KRT10 MYH10 MYH11 WAS ANK2 KRT17 ANK3 KRT18 NDE1 MAP6 DSP KRT27 MYH7B TTLL5 ODF2 CCDC57 GFAP TBCB NEFH NEFL MISP ACTL8 LMNA SLMAP MACF1 MYBPHL PLEC KRT25 DYNC1I2 DNAH11 | 7.88e-09 | 1187 | 180 | 32 | GO:0099081 |
| GeneOntologyCellularComponent | intermediate filament | KRT72 VIM KRT10 KRT17 KRT18 DSP KRT27 GFAP NEFH NEFL LMNA MACF1 PLEC KRT25 | 1.11e-08 | 227 | 180 | 14 | GO:0005882 |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | KRT72 VIM KRT10 KRT17 KRT18 DSP KRT27 GFAP NEFH NEFL LMNA MACF1 PLEC KRT25 | 7.04e-08 | 263 | 180 | 14 | GO:0045111 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KRT72 VIM KRT10 WAS KRT17 KRT18 NDE1 MAP6 DSP KRT27 TTLL5 ODF2 CCDC57 GFAP TBCB NEFH NEFL MISP ACTL8 LMNA MACF1 PLEC KRT25 DYNC1I2 DNAH11 | 2.35e-07 | 899 | 180 | 25 | GO:0099513 |
| GeneOntologyCellularComponent | myosin complex | 1.16e-05 | 59 | 180 | 6 | GO:0016459 | |
| GeneOntologyCellularComponent | nuclear periphery | 1.79e-05 | 171 | 180 | 9 | GO:0034399 | |
| GeneOntologyCellularComponent | centrosome | RABEP2 KRT18 NDE1 LRRC45 TTLL5 CNTRL CHD3 ODF2 CCDC57 CCDC38 MISP CEP20 CEP250 MAD1L1 SLMAP CROCC FLOT1 DYNC1I2 PCNA | 3.84e-05 | 770 | 180 | 19 | GO:0005813 |
| GeneOntologyCellularComponent | microtubule organizing center | RABEP2 VIM KRT18 NDE1 LRRC45 TTLL5 CNTRL CHD3 ODF2 CCDC57 CCDC38 MISP CEP20 CEP250 MAD1L1 SLMAP CROCC FLOT1 DYNC1I2 PCNA | 1.34e-04 | 919 | 180 | 20 | GO:0005815 |
| GeneOntologyCellularComponent | cell-cell junction | AKAP6 CDC42BPA WAS ANK2 ANK3 KRT18 DSP SNAP23 ITGA6 PTPRU FRMD4A CGN CGNL1 FLOT1 CDH6 | 1.92e-04 | 591 | 180 | 15 | GO:0005911 |
| GeneOntologyCellularComponent | nuclear matrix | 2.14e-04 | 140 | 180 | 7 | GO:0016363 | |
| GeneOntologyCellularComponent | laminin-11 complex | 2.20e-04 | 3 | 180 | 2 | GO:0043260 | |
| GeneOntologyCellularComponent | anchoring junction | AKAP6 VIM STARD8 CDC42BPA WAS ANK2 ANK3 KRT18 DSP SNAP23 ITGA6 PTPRU PRX FRMD4A MISP CGN CGNL1 PLEC FLOT1 CDH6 | 2.96e-04 | 976 | 180 | 20 | GO:0070161 |
| GeneOntologyCellularComponent | brush border | 3.54e-04 | 152 | 180 | 7 | GO:0005903 | |
| GeneOntologyCellularComponent | spindle pole | 4.13e-04 | 205 | 180 | 8 | GO:0000922 | |
| GeneOntologyCellularComponent | postsynaptic intermediate filament cytoskeleton | 4.37e-04 | 4 | 180 | 2 | GO:0099160 | |
| GeneOntologyCellularComponent | calpain complex | 4.37e-04 | 4 | 180 | 2 | GO:0110158 | |
| GeneOntologyCellularComponent | mitotic spindle pole | 5.05e-04 | 43 | 180 | 4 | GO:0097431 | |
| GeneOntologyCellularComponent | spindle pole centrosome | 5.50e-04 | 19 | 180 | 3 | GO:0031616 | |
| GeneOntologyCellularComponent | cilium | RABEP2 NPR2 RSPH4A TTLL5 CNTRL RAPGEF4 ODF2 LRRC43 ACE CCDC38 CEP20 MROH2B CEP250 ARL13B CFAP74 CROCC DYNC1I2 DNAH11 | 7.73e-04 | 898 | 180 | 18 | GO:0005929 |
| GeneOntologyCellularComponent | centriolar satellite | 8.54e-04 | 128 | 180 | 6 | GO:0034451 | |
| GeneOntologyCellularComponent | costamere | 8.57e-04 | 22 | 180 | 3 | GO:0043034 | |
| GeneOntologyCellularComponent | basal plasma membrane | 1.03e-03 | 354 | 180 | 10 | GO:0009925 | |
| GeneOntologyCellularComponent | motile cilium | RSPH4A ODF2 ACE CCDC38 CEP20 MROH2B ARL13B CFAP74 CROCC DNAH11 | 1.05e-03 | 355 | 180 | 10 | GO:0031514 |
| GeneOntologyCellularComponent | 9+2 motile cilium | 1.09e-03 | 238 | 180 | 8 | GO:0097729 | |
| GeneOntologyCellularComponent | myosin filament | 1.26e-03 | 25 | 180 | 3 | GO:0032982 | |
| GeneOntologyCellularComponent | cell-cell contact zone | 1.32e-03 | 94 | 180 | 5 | GO:0044291 | |
| GeneOntologyCellularComponent | postsynaptic cytoskeleton | 1.41e-03 | 26 | 180 | 3 | GO:0099571 | |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH10 MYH11 CDC42BPA WAS MYH7B MISP ACTL8 CGN MACF1 MYH16 CGNL1 CROCC FLOT1 | 1.50e-03 | 576 | 180 | 13 | GO:0015629 |
| GeneOntologyCellularComponent | mitotic cohesin complex | 1.51e-03 | 7 | 180 | 2 | GO:0030892 | |
| GeneOntologyCellularComponent | keratin filament | 1.52e-03 | 97 | 180 | 5 | GO:0045095 | |
| GeneOntologyCellularComponent | basal part of cell | 1.67e-03 | 378 | 180 | 10 | GO:0045178 | |
| GeneOntologyCellularComponent | myosin II complex | 1.76e-03 | 28 | 180 | 3 | GO:0016460 | |
| GeneOntologyCellularComponent | axoneme | 2.15e-03 | 207 | 180 | 7 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 2.21e-03 | 208 | 180 | 7 | GO:0097014 | |
| GeneOntologyCellularComponent | adherens junction | 2.46e-03 | 212 | 180 | 7 | GO:0005912 | |
| GeneOntologyCellularComponent | chromosome, centromeric region | 2.77e-03 | 276 | 180 | 8 | GO:0000775 | |
| GeneOntologyCellularComponent | intercalated disc | 2.82e-03 | 68 | 180 | 4 | GO:0014704 | |
| GeneOntologyCellularComponent | neuromuscular junction | 2.86e-03 | 112 | 180 | 5 | GO:0031594 | |
| GeneOntologyCellularComponent | centriolar subdistal appendage | 3.17e-03 | 10 | 180 | 2 | GO:0120103 | |
| GeneOntologyCellularComponent | caspase complex | 3.17e-03 | 10 | 180 | 2 | GO:0008303 | |
| GeneOntologyCellularComponent | laminin complex | 3.17e-03 | 10 | 180 | 2 | GO:0043256 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 3.26e-03 | 223 | 180 | 7 | GO:0098862 | |
| GeneOntologyCellularComponent | chromosomal region | STAG1 NDE1 SMC1A NUP98 IKZF1 KAT7 MAD1L1 NCAPD2 PCNA NSMCE4A | 3.63e-03 | 421 | 180 | 10 | GO:0098687 |
| GeneOntologyCellularComponent | contractile muscle fiber | 3.74e-03 | 290 | 180 | 8 | GO:0043292 | |
| GeneOntologyCellularComponent | cohesin complex | 3.85e-03 | 11 | 180 | 2 | GO:0008278 | |
| GeneOntologyCellularComponent | hemidesmosome | 3.85e-03 | 11 | 180 | 2 | GO:0030056 | |
| GeneOntologyCellularComponent | axon | TANC2 VIM MYH10 ANK3 MAP6 ADAM21 NTRK1 RAPGEF4 GRM4 NEFH NEFL ORAI1 ROBO1 PLEC ROBO3 DAGLA | 4.49e-03 | 891 | 180 | 16 | GO:0030424 |
| Domain | Filament | 6.34e-11 | 71 | 177 | 11 | SM01391 | |
| Domain | IF | 7.42e-11 | 72 | 177 | 11 | PS00226 | |
| Domain | Filament | 8.67e-11 | 73 | 177 | 11 | PF00038 | |
| Domain | IF | 1.36e-10 | 76 | 177 | 11 | IPR001664 | |
| Domain | Intermediate_filament_CS | 7.67e-09 | 63 | 177 | 9 | IPR018039 | |
| Domain | Keratin_I | 1.74e-07 | 44 | 177 | 7 | IPR002957 | |
| Domain | Myosin_tail_1 | 5.60e-07 | 18 | 177 | 5 | PF01576 | |
| Domain | Myosin_tail | 5.60e-07 | 18 | 177 | 5 | IPR002928 | |
| Domain | ARM-like | STAG1 COPB1 DOCK8 ARFGEF1 NBEA TRRAP TRIP12 MROH2B NCAPD2 LRBA GCN1 GPRASP2 | 1.06e-05 | 270 | 177 | 12 | IPR011989 |
| Domain | - | 1.64e-05 | 6 | 177 | 3 | 3.90.1290.10 | |
| Domain | Plectin | 2.85e-05 | 7 | 177 | 3 | PF00681 | |
| Domain | Filament_head | 2.85e-05 | 7 | 177 | 3 | PF04732 | |
| Domain | Plectin_repeat | 2.85e-05 | 7 | 177 | 3 | IPR001101 | |
| Domain | Intermed_filament_DNA-bd | 2.85e-05 | 7 | 177 | 3 | IPR006821 | |
| Domain | PLEC | 2.85e-05 | 7 | 177 | 3 | SM00250 | |
| Domain | TC1 | 8.93e-05 | 2 | 177 | 2 | PF15063 | |
| Domain | DUF1088 | 8.93e-05 | 2 | 177 | 2 | IPR010508 | |
| Domain | Arg_vasopressin-induced_prot_1 | 8.93e-05 | 2 | 177 | 2 | PD287216 | |
| Domain | Avpi1/C8orf4 | 8.93e-05 | 2 | 177 | 2 | IPR020282 | |
| Domain | DUF1088 | 8.93e-05 | 2 | 177 | 2 | PF06469 | |
| Domain | ARM-type_fold | STAG1 COPB1 DOCK8 ARFGEF1 NBEA TRRAP TRIP12 MROH2B NCAPD2 LRBA GCN1 GPRASP2 | 9.78e-05 | 339 | 177 | 12 | IPR016024 |
| Domain | SPEC | 2.28e-04 | 32 | 177 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 2.28e-04 | 32 | 177 | 4 | IPR018159 | |
| Domain | JAKMIP_C | 2.66e-04 | 3 | 177 | 2 | IPR031994 | |
| Domain | JAKMIP_CC3 | 2.66e-04 | 3 | 177 | 2 | PF16034 | |
| Domain | JAKMIP | 2.66e-04 | 3 | 177 | 2 | IPR024836 | |
| Domain | Myosin_N | 3.50e-04 | 15 | 177 | 3 | PF02736 | |
| Domain | Myosin_N | 3.50e-04 | 15 | 177 | 3 | IPR004009 | |
| Domain | Prefoldin | 6.05e-04 | 72 | 177 | 5 | IPR009053 | |
| Domain | Myosin-like_IQ_dom | 7.25e-04 | 19 | 177 | 3 | IPR027401 | |
| Domain | - | 7.25e-04 | 19 | 177 | 3 | 4.10.270.10 | |
| Domain | Myosin_S1_N | 8.76e-04 | 5 | 177 | 2 | IPR008989 | |
| Domain | DUF4704 | 8.76e-04 | 5 | 177 | 2 | IPR031570 | |
| Domain | DUF4704 | 8.76e-04 | 5 | 177 | 2 | PF15787 | |
| Domain | - | 1.28e-03 | 222 | 177 | 8 | 1.25.10.10 | |
| Domain | PH_BEACH | 1.31e-03 | 6 | 177 | 2 | PF14844 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 5.92e-06 | 102 | 135 | 8 | M27648 | |
| Pathway | REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT | 1.88e-05 | 156 | 135 | 9 | M27097 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 1.95e-05 | 87 | 135 | 7 | MM15351 | |
| Pathway | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS | 2.55e-05 | 37 | 135 | 5 | MM14488 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | STAG1 NDE1 SMC1A CNTRL NUP98 ODF2 CEP250 MAD1L1 NCAPD2 DYNC1I2 | 2.65e-05 | 204 | 135 | 10 | M4217 |
| Pathway | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS | 2.91e-05 | 38 | 135 | 5 | M495 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 3.31e-05 | 129 | 135 | 8 | M27649 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 3.91e-05 | 66 | 135 | 6 | MM15925 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | VGF AMER1 ANK2 ANK3 STAG1 COPB1 NSF SMC1A TTLL5 NUP98 NAPG LAMB2 CHD3 TRRAP TMED3 ATXN3L RNF123 ARRB1 SEC24C SATB1 JMJD6 OTUD7A UBA6 PEX5 MUC5AC GOLGB1 DYNC1I2 PCNA NSMCE4A ALG13 | 4.94e-05 | 1475 | 135 | 30 | M19806 |
| Pathway | REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION | 7.80e-05 | 187 | 135 | 9 | M961 | |
| Pathway | REACTOME_APOPTOTIC_EXECUTION_PHASE | 1.02e-04 | 49 | 135 | 5 | MM15448 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 1.34e-04 | 11 | 135 | 3 | M158 | |
| Pathway | REACTOME_APOPTOTIC_EXECUTION_PHASE | 1.35e-04 | 52 | 135 | 5 | M2341 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 1.41e-04 | 202 | 135 | 9 | MM15362 | |
| Pathway | REACTOME_RHOJ_GTPASE_CYCLE | 1.77e-04 | 55 | 135 | 5 | M41815 | |
| Pathway | WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION | 2.89e-04 | 14 | 135 | 3 | M39772 | |
| Pathway | REACTOME_AURKA_ACTIVATION_BY_TPX2 | 6.26e-04 | 72 | 135 | 5 | M27749 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 6.54e-04 | 110 | 135 | 6 | MM15350 | |
| Pathway | REACTOME_KERATINIZATION | 6.72e-04 | 153 | 135 | 7 | MM15343 | |
| Pathway | REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION | 7.41e-04 | 307 | 135 | 10 | M894 | |
| Pubmed | MYH10 MYH11 CDC42BPA WAS KRT17 ANK3 KRT18 DSP EXPH5 CNTRL NUP98 LAMB2 GFAP MAP3K4 NSD3 ARRB1 MAP4K5 CEP250 ROBO1 MACF1 CGNL1 PLEC GCN1 GOLGB1 | 1.16e-16 | 486 | 181 | 24 | 20936779 | |
| Pubmed | KRT72 VIM FAM184B KRT10 MYH10 MYH11 AMER1 H3-5 ANK2 KRT17 STAG1 KRT18 DSP MYH7B CNTRL NUP98 CHD3 ODF2 LRRC43 CCDC57 TRIP12 PRX TBCB NEFL MYPOP ARRB1 LMNA NCAPD2 MACF1 CFAP74 EIF2AK4 PLEC GOLGB1 DYNC1I2 NSMCE4A | 2.37e-14 | 1442 | 181 | 35 | 35575683 | |
| Pubmed | VIM KRT10 AMER1 CDC42BPA KRT17 ANK3 COPB1 CNTRL BMS1 NUP98 SNAP23 ARFGEF1 NBEA MCCC1 TRIP12 VIPAS39 SEC24C ARL13B PEX5 ROBO1 CGNL1 LRBA GCN1 GOLGB1 PCNA | 4.31e-13 | 777 | 181 | 25 | 35844135 | |
| Pubmed | VGF TANC2 RABEP2 VIM MYH10 NYAP2 ANK2 ANK3 MAP6 NSF RAPGEF4 MCC NBEA JAKMIP3 GRM4 JAKMIP2 ITIH1 NEFH NEFL SEC24C MAD1L1 UBA6 PEX5 MACF1 RABGEF1 GOLGB1 LRRFIP2 | 1.15e-12 | 963 | 181 | 27 | 28671696 | |
| Pubmed | AKAP6 VIM ANK2 ANK3 STAG1 COPB1 DSP SMC1A TTLL5 RAPGEF4 POLE4 NBEA JAKMIP3 ODF2 CBFB TRIP12 GFAP RBCK1 NEFL RNF123 ARRB1 SATB1 ARL13B ROBO1 MACF1 PCMTD2 PLEC LRBA FLOT1 GPRASP2 | 5.70e-12 | 1285 | 181 | 30 | 35914814 | |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | ANKRD13B KRT72 VIM KRT10 MYH10 KRT17 KRT18 MAP6 DSP CNTRL GFAP ANGPTL6 LMNA ARL13B OSR1 PCMTD2 PLEC GCN1 MUC5AC GOLGB1 | 1.99e-11 | 564 | 181 | 20 | 21565611 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | KRT17 KRT18 COPB1 DSP NSF SMC1A NUP98 SNAP23 LAMB2 UFL1 CHD3 TRRAP TRIP12 NEFL SEC24C LMNA CGN UBA6 PEX5 MACF1 PLEC SNRPA1 FLOT1 GCN1 GOLGB1 PCNA | 2.81e-11 | 1024 | 181 | 26 | 24711643 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | TANC2 VIM STAG1 COPB1 DSP NSF DOCK8 SMC1A CHD3 TRIP12 SEC24C LMNA MAD1L1 NCAPD2 MACF1 TNFAIP2 PLEC SNRPA1 GCN1 GOLGB1 | 3.48e-11 | 582 | 181 | 20 | 20467437 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | KRT10 MYH10 MYH11 CDC42BPA DSP BMS1 TRIP12 ARHGEF40 TMTC3 NCAPD2 EIF2AK4 PLEC GCN1 | 5.71e-11 | 202 | 181 | 13 | 33005030 |
| Pubmed | TANC2 KRT72 VIM KRT10 MYH10 MYH11 ANK2 ANK3 COPB1 MAP6 DSP NSF DOCK8 RAPGEF4 NBEA CHD3 GFAP NEFH NEFL MISP SEC24C LMNA MACF1 CGNL1 PLEC CROCC FLOT1 DAGLA LRRFIP2 DNAH11 | 7.90e-11 | 1431 | 181 | 30 | 37142655 | |
| Pubmed | VIM KRT10 MYH10 KRT17 KRT18 DSP CAPNS1 LAMA5 MCCC1 MISP LMNA CGN MACF1 PLEC FLOT1 GCN1 DYNC1I2 PCNA | 1.13e-10 | 488 | 181 | 18 | 31324722 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | RABEP2 VIM KRT17 KRT18 COPB1 SMC1A CAPNS1 NUP98 LAMB2 ATP6V1F XPNPEP1 TBCB RNF123 SEC24C LMNA JMJD6 MAD1L1 NCAPD2 UBA6 PEX5 MACF1 RABGEF1 TIMELESS PLEC LRBA CROCC SNRPA1 GCN1 DYNC1I2 PCNA | 1.18e-10 | 1455 | 181 | 30 | 22863883 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | MYH10 AMER1 NDE1 DSP TTLL5 TMED5 CNTRL SNAP23 MCCC1 ODF2 ACE CCDC57 TBCB CEP20 CEP250 CGN PEX5 CGNL1 PLEC FLOT1 DYNC1I2 PCNA | 7.98e-10 | 853 | 181 | 22 | 28718761 |
| Pubmed | RABEP2 VIM MYH10 KRT18 NUP98 MCCC1 LMNA MAP4K5 CGN SLMAP MACF1 PLEC GOLGB1 DYNC1I2 PCNA | 8.21e-10 | 360 | 181 | 15 | 33111431 | |
| Pubmed | STAG1 COPB1 DSP NSF SMC1A TRRAP TRIP12 LIN9 MISP LMNA ANKRD11 PLEC GCN1 | 2.21e-09 | 272 | 181 | 13 | 31010829 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | VIM MYH10 KRT18 COPB1 SMC1A CHD3 TSPYL1 TRRAP TRIP12 NSD3 KAT7 SEC24C LMNA DYNC1I2 PCNA | 2.80e-09 | 394 | 181 | 15 | 27248496 |
| Pubmed | NDE1 DOCK8 NTRK1 RAPGEF4 SNAP23 IKZF1 CCDC57 RBCK1 NEFL RBFOX1 OTUD7A ANKRD11 RABGEF1 GPRASP2 ALG13 | 3.67e-09 | 402 | 181 | 15 | 24722188 | |
| Pubmed | RABEP2 VIM MYH10 CDC42BPA KRT17 ANK3 KRT18 ELP5 DSP BMS1 NUP98 ITGA6 NBEA PTPRU ODF2 NSD3 NEFL VIPAS39 CGN ARL13B ROBO1 EIF2AK4 GCN1 | 6.93e-09 | 1049 | 181 | 23 | 27880917 | |
| Pubmed | 1.33e-08 | 54 | 181 | 7 | 22266860 | ||
| Pubmed | MYH10 ANK3 STAG1 DOCK8 EXPH5 LAMA5 LAMB2 CHD3 TRIP12 RNF123 CEP250 UBA6 MACF1 RABGEF1 PLEC RUBCN GOLGB1 | 1.55e-08 | 591 | 181 | 17 | 15231748 | |
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | 2.36e-08 | 219 | 181 | 11 | 31353912 | |
| Pubmed | COPB1 DSP NSF SMC1A UFL1 TRIP12 CGN NCAPD2 SLMAP ROBO1 SNRPA1 GCN1 DYNC1I2 PCNA | 2.67e-08 | 399 | 181 | 14 | 37536630 | |
| Pubmed | CDK7/GRP78 signaling axis contributes to tumor growth and metastasis in osteosarcoma. | VIM MYH10 KRT18 COPB1 DSP CNTRL CAPNS1 SNAP23 GRAMD4 MISP ANKRD11 PLEC SNRPA1 DYNC1I2 PCNA | 2.77e-08 | 468 | 181 | 15 | 36042349 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TANC2 VIM AMER1 CDC42BPA KRT18 DSP EXPH5 USP43 MCCC1 TRIP12 NSD3 CGN MAD1L1 OTUD7A ANKRD11 MACF1 RABGEF1 CGNL1 PLEC GOLGB1 | 2.81e-08 | 861 | 181 | 20 | 36931259 |
| Pubmed | 3.14e-08 | 131 | 181 | 9 | 28634551 | ||
| Pubmed | CDC42BPA ANK2 ANK3 COPB1 DSP NSF SMC1A XPNPEP1 SEC24C MAP4K5 NCAPD2 UBA6 ROBO1 MACF1 LRBA SNRPA1 GCN1 GOLGB1 | 3.77e-08 | 708 | 181 | 18 | 39231216 | |
| Pubmed | ANKRD13B RABEP2 NDE1 LAMA5 TRIP12 RBCK1 ATXN3L RNF123 ACTL8 SLMAP UBA6 MACF1 RABGEF1 PCMTD2 PLEC | 3.96e-08 | 481 | 181 | 15 | 28190767 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | KRT72 KRT10 MYH10 KRT17 KRT18 DSP EXPH5 SMC1A CAPNS1 BMS1 NUP98 ITGA6 TRIP12 NSD3 MISP LMNA MRPS26 CGN SLMAP PLEC SNRPA1 FLOT1 PCNA LRRFIP2 | 4.40e-08 | 1257 | 181 | 24 | 36526897 |
| Pubmed | Patterned neuropathologic events occurring in hyh congenital hydrocephalic mutant mice. | 4.89e-08 | 8 | 181 | 4 | 18090917 | |
| Pubmed | MYH10 KRT18 COPB1 DSP NSF SMC1A ARFGEF1 LRRK1 SEC24C LMNA PCMTD2 PLEC GCN1 DYNC1I2 PCNA | 5.61e-08 | 494 | 181 | 15 | 26831064 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | RABEP2 ANK3 EXPH5 RAPGEF4 NBEA CCDC57 TRRAP TRIP12 MAP3K4 TRANK1 NCAPD2 ANKRD11 UBA6 EIF2AK4 LRBA | 6.07e-08 | 497 | 181 | 15 | 36774506 |
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | VIM KRT10 MYH10 MYH11 KRT17 KRT18 COPB1 DSP SNAP23 MISP LMNA PLEC FLOT1 GOLGB1 PCNA LRRFIP2 | 7.42e-08 | 580 | 181 | 16 | 35676659 |
| Pubmed | 8.04e-08 | 146 | 181 | 9 | 21399614 | ||
| Pubmed | 8.76e-08 | 9 | 181 | 4 | 7720210 | ||
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | KRT18 COPB1 DSP NUP98 CHD3 MISP ROBO1 PLEC SNRPA1 GCN1 GOLGB1 | 1.16e-07 | 256 | 181 | 11 | 33397691 |
| Pubmed | TANC2 VIM MYH10 NYAP2 CDC42BPA ANK2 ANK3 MAP6 DSP NBEA MCCC1 GFAP TBCB FRMD4A VIPAS39 LMNA MACF1 RABGEF1 PLEC SNRPA1 FLOT1 GCN1 | 1.38e-07 | 1139 | 181 | 22 | 36417873 | |
| Pubmed | 1.39e-07 | 3 | 181 | 3 | 28814779 | ||
| Pubmed | 1.45e-07 | 10 | 181 | 4 | 24940650 | ||
| Pubmed | VIM KRT10 MYH10 KRT18 COPB1 CAPNS1 SNAP23 NAPG SEC24C LMNA MACF1 PLEC LRBA SNRPA1 FLOT1 GCN1 PCNA | 2.02e-07 | 707 | 181 | 17 | 19738201 | |
| Pubmed | Stage-specific expression of alkaline phosphatase during neural development in the mouse. | 2.28e-07 | 11 | 181 | 4 | 7533563 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | VIM KRT10 MYH10 CDC42BPA MAP6 DSP SMC1A BMS1 UFL1 TRRAP TRIP12 NSD3 NEFL SEC24C LMNA RBFOX1 MACF1 PLEC SNRPA1 FLOT1 GCN1 | 2.51e-07 | 1082 | 181 | 21 | 38697112 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | VIM KRT10 MYH10 MYH11 ANK3 COPB1 DSP CNTRL CAPNS1 XPNPEP1 MCCC1 ACE LMNA MACF1 PLEC LRBA GCN1 ALG13 | 2.62e-07 | 807 | 181 | 18 | 30575818 |
| Pubmed | VIM KRT10 MYH10 KRT17 COPB1 DSP EXPH5 SMC1A BMS1 NUP98 CHD3 GFAP TBCB LMNA NCAPD2 GCN1 | 2.85e-07 | 641 | 181 | 16 | 36057605 | |
| Pubmed | TANC2 STARD8 CDC42BPA COPB1 DOCK8 SMC1A NUP98 NBEA MCCC1 NEFL ARHGEF40 LMNA MRPS26 CGN ROBO1 PLEC FLOT1 GCN1 PCNA | 3.61e-07 | 916 | 181 | 19 | 32203420 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | VIM KRT10 MYH10 KRT17 KRT18 DSP SMC1A CAPNS1 UFL1 ARRB1 SEC24C ACTL8 LMNA JMJD6 MRPS26 NCAPD2 UBA6 MACF1 PLEC SNRPA1 GCN1 GOLGB1 DYNC1I2 PCNA | 3.82e-07 | 1415 | 181 | 24 | 28515276 |
| Pubmed | 4.64e-07 | 234 | 181 | 10 | 36243803 | ||
| Pubmed | 4.89e-07 | 13 | 181 | 4 | 36350252 | ||
| Pubmed | 4.89e-07 | 13 | 181 | 4 | 9670011 | ||
| Pubmed | Protein-protein interactions between keratin polypeptides expressed in the yeast two-hybrid system. | 5.52e-07 | 4 | 181 | 3 | 9630597 | |
| Pubmed | 5.52e-07 | 4 | 181 | 3 | 6188955 | ||
| Pubmed | E3 Ligase Trim21 Ubiquitylates and Stabilizes Keratin 17 to Induce STAT3 Activation in Psoriasis. | 5.81e-07 | 135 | 181 | 8 | 29859926 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | VIM MYH10 KRT18 COPB1 DSP SMC1A BMS1 MCCC1 TRRAP TRIP12 TBCB KAT7 ARHGEF40 SEC24C LMNA MAP4K5 NCAPD2 MACF1 PLEC SNRPA1 GCN1 DYNC1I2 PCNA | 6.58e-07 | 1353 | 181 | 23 | 29467282 |
| Pubmed | 7.25e-07 | 60 | 181 | 6 | 20682791 | ||
| Pubmed | 7.84e-07 | 191 | 181 | 9 | 33762435 | ||
| Pubmed | 9.71e-07 | 63 | 181 | 6 | 16831889 | ||
| Pubmed | 1.01e-06 | 197 | 181 | 9 | 23686814 | ||
| Pubmed | MYH10 KRT18 DSP BMS1 SNAP23 LAMA5 UFL1 TRRAP TRIP12 NSD3 MISP ARHGEF40 SEC24C TMTC3 MRPS26 LPL MAPKAPK3 ROBO1 MACF1 CROCC FLOT1 PCNA | 1.22e-06 | 1297 | 181 | 22 | 33545068 | |
| Pubmed | 1.36e-06 | 204 | 181 | 9 | 25659154 | ||
| Pubmed | 1.38e-06 | 5 | 181 | 3 | 12403814 | ||
| Pubmed | CCDC102B functions in centrosome linker assembly and centrosome cohesion. | 1.38e-06 | 5 | 181 | 3 | 30404835 | |
| Pubmed | Basal enrichment within neuroepithelia suggests novel function(s) for Celsr1 protein. | 1.38e-06 | 5 | 181 | 3 | 20353824 | |
| Pubmed | Multiple functions of the integrin alpha6beta4 in epidermal homeostasis and tumorigenesis. | 1.38e-06 | 5 | 181 | 3 | 16581764 | |
| Pubmed | Different expression of synemin isoforms in glia and neurons during nervous system development. | 1.38e-06 | 5 | 181 | 3 | 16817202 | |
| Pubmed | VIM MYH10 COPB1 NSF SMC1A NUP98 UFL1 SEC24C LMNA NCAPD2 PLEC LRBA SNRPA1 GCN1 DYNC1I2 | 1.43e-06 | 638 | 181 | 15 | 33239621 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | KRT72 VIM MYH10 MYH11 KRT18 COPB1 DSP MYH7B LAMA5 SEC24C LMNA NCAPD2 PLEC LRBA LRRFIP2 | 1.70e-06 | 647 | 181 | 15 | 26618866 |
| Pubmed | MYH10 COPB1 DSP BMS1 NUP98 TRRAP TRIP12 NEFL SEC24C LMNA CGN NCAPD2 MACF1 PLEC GCN1 | 1.90e-06 | 653 | 181 | 15 | 22586326 | |
| Pubmed | KRT10 MYH10 COPB1 SMC1A BMS1 NUP98 IKZF1 TRIP12 CEP250 PLEC SNRPA1 | 1.90e-06 | 340 | 181 | 11 | 29478914 | |
| Pubmed | Hemidesmosome integrity protects the colon against colitis and colorectal cancer. | 2.05e-06 | 18 | 181 | 4 | 27371534 | |
| Pubmed | PLB1 H3-5 NDE1 DSP NSF SMC1A CNTRL LAMA5 TRRAP MISP SEC24C RBFOX1 GNAL GOLGB1 PCNA LRRFIP2 | 2.37e-06 | 754 | 181 | 16 | 35906200 | |
| Pubmed | MYH10 CDC42BPA KRT18 SMC1A BMS1 NUP98 LAMA5 CHD3 TSPYL1 TRRAP TRIP12 NSD3 KAT7 MRPS26 SNRPA1 FLOT1 LRRFIP2 | 2.39e-06 | 847 | 181 | 17 | 35850772 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | MYH10 MYH11 COPB1 DSP SMC1A TMED5 MCC CHD3 NEFL MRPS26 CEP250 NCAPD2 MACF1 PLEC FLOT1 GOLGB1 DYNC1I2 | 2.39e-06 | 847 | 181 | 17 | 35235311 |
| Pubmed | 2.59e-06 | 19 | 181 | 4 | 24421332 | ||
| Pubmed | 2.59e-06 | 19 | 181 | 4 | 25245017 | ||
| Pubmed | 2.74e-06 | 6 | 181 | 3 | 9786956 | ||
| Pubmed | 2.74e-06 | 6 | 181 | 3 | 11566879 | ||
| Pubmed | 2.74e-06 | 6 | 181 | 3 | 10671376 | ||
| Pubmed | Cep44 functions in centrosome cohesion by stabilizing rootletin. | 2.74e-06 | 6 | 181 | 3 | 31974111 | |
| Pubmed | Robo1 regulates the development of major axon tracts and interneuron migration in the forebrain. | 2.74e-06 | 6 | 181 | 3 | 16690755 | |
| Pubmed | KRT72 VIM KRT10 MYH11 KRT17 KRT18 COPB1 DSP NSF KRT27 SMC1A CHD3 GFAP MRPS26 NCAPD2 MACF1 SNRPA1 KRT25 DYNC1I2 PCNA | 2.76e-06 | 1153 | 181 | 20 | 29845934 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | MYH10 STAG1 DSP NSF SMC1A BMS1 NUP98 UFL1 TRRAP TRIP12 LIN9 SATB1 MAD1L1 MAPKAPK3 NCAPD2 SLMAP LRRFIP2 | 2.80e-06 | 857 | 181 | 17 | 25609649 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | STAG1 COPB1 NDE1 SMC1A NUP98 MCC LIN9 MISP ARRB1 MRPS26 MAD1L1 TIMELESS GNAL SNRPA1 FLOT1 GCN1 DYNC1I2 PCNA LRRFIP2 NSMCE4A | 2.83e-06 | 1155 | 181 | 20 | 20360068 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | VIM MYH10 KRT18 COPB1 DSP NSF BMS1 NUP98 ARFGEF1 NAPG ITGA6 XPNPEP1 MCCC1 TBCB MISP NCAPD2 UBA6 SNRPA1 GCN1 GOLGB1 DYNC1I2 PCNA | 2.85e-06 | 1367 | 181 | 22 | 32687490 |
| Pubmed | VIM MYH10 MYH11 CDC42BPA ANK2 COPB1 DSP CAPNS1 BMS1 SNAP23 CHD3 TRIP12 ARHGEF40 SEC24C CGN EIF2AK4 PLEC FLOT1 GCN1 MUC5AC PCNA LRRFIP2 | 2.99e-06 | 1371 | 181 | 22 | 36244648 | |
| Pubmed | FAM184B CDC42BPA ANK2 ANK3 NSF TTLL5 BMS1 SNAP23 UFL1 ATP6V1F SEC24C LMNA TMTC3 MAP4K5 MRPS26 ARL13B SLMAP ANKRD11 UBA6 ROBO1 MACF1 FLOT1 GOLGB1 | 3.22e-06 | 1487 | 181 | 23 | 33957083 | |
| Pubmed | 4.15e-06 | 124 | 181 | 7 | 35516420 | ||
| Pubmed | 4.16e-06 | 46 | 181 | 5 | 36147463 | ||
| Pubmed | AKAP6 NYAP2 CDC42BPA BMS1 LAMA5 UFL1 LRRK1 GRAMD4 TRANK1 NCAPD2 SLMAP EIF2AK4 DAGLA | 4.57e-06 | 529 | 181 | 13 | 14621295 | |
| Pubmed | 4.78e-06 | 7 | 181 | 3 | 16818453 | ||
| Pubmed | 4.78e-06 | 7 | 181 | 3 | 18558633 | ||
| Pubmed | 5.12e-06 | 128 | 181 | 7 | 23858473 | ||
| Pubmed | KRT72 VIM MYH10 CDC42BPA KRT17 KRT18 COPB1 SMC1A CHD3 NEFH NEFL MACF1 PCNA | 5.48e-06 | 538 | 181 | 13 | 28524877 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TANC2 B4GALNT4 CDC42BPA LAMA5 LAMB2 LRRK1 TRRAP PLEKHH3 NSD3 ORAI1 ARHGEF40 MAD1L1 NCAPD2 ANKRD11 TNFAIP2 PLEC LRBA GCN1 PPP1R16A | 5.63e-06 | 1105 | 181 | 19 | 35748872 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | VIM KRT10 MYH10 COPB1 NSF SMC1A TMED5 BMS1 NUP98 UFL1 IKZF1 MCCC1 TRIP12 SEC24C LMNA JMJD6 PLEC LRBA SNRPA1 GCN1 PCNA | 5.69e-06 | 1318 | 181 | 21 | 30463901 |
| Pubmed | VIM MYH10 AMER1 CDC42BPA COPB1 DSP SMC1A TBCB SEC24C LMNA MRPS26 NCAPD2 PLEC SNRPA1 GCN1 DYNC1I2 | 5.77e-06 | 809 | 181 | 16 | 32129710 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | MYH10 KRT17 KRT18 NSF SMC1A BMS1 NUP98 USP43 TRRAP TRIP12 MRPS26 SLMAP EIF2AK4 GNAL PLEC SNRPA1 GCN1 GPRASP2 | 5.79e-06 | 1005 | 181 | 18 | 19615732 |
| Pubmed | 6.11e-06 | 312 | 181 | 10 | 37120454 | ||
| Pubmed | 6.65e-06 | 187 | 181 | 8 | 26460568 | ||
| Pubmed | Proteomic and biochemical analysis of 14-3-3-binding proteins during C2-ceramide-induced apoptosis. | 6.96e-06 | 88 | 181 | 6 | 20618440 | |
| Pubmed | A trimeric Rab7 GEF controls NPC1-dependent lysosomal cholesterol export. | MYH10 NSF TMED5 PLEKHH3 MISP SEC24C SNRPA1 FLOT1 GCN1 PCNA LRRFIP2 | 7.37e-06 | 392 | 181 | 11 | 33144569 |
| Pubmed | 7.62e-06 | 8 | 181 | 3 | 16481432 | ||
| Interaction | SYNC interactions | 7.72e-09 | 67 | 179 | 9 | int:SYNC | |
| Interaction | CCDC8 interactions | H3-5 KRT18 COPB1 DSP NSF SMC1A SNAP23 LAMB2 UFL1 CHD3 TRIP12 NEFL LMNA CEP250 CGN UBA6 PEX5 MACF1 PLEC FLOT1 GCN1 GPRASP2 GOLGB1 | 2.07e-08 | 656 | 179 | 23 | int:CCDC8 |
| Interaction | LRRC31 interactions | KRT10 MYH10 MYH11 CDC42BPA DSP BMS1 TRIP12 ARHGEF40 TMTC3 NCAPD2 EIF2AK4 PLEC GCN1 | 3.87e-08 | 205 | 179 | 13 | int:LRRC31 |
| Interaction | YWHAG interactions | TANC2 VIM MYH10 AMER1 CDC42BPA KRT18 COPB1 NDE1 DSP EXPH5 NTRK1 CAPNS1 USP43 MCC TRRAP TRIP12 FRMD4A NEFL ARRB1 LMNA MAP4K5 CEP250 CGN MAD1L1 OTUD7A ANKRD11 MACF1 RABGEF1 CGNL1 LRBA RUBCN GPRASP2 | 5.22e-08 | 1248 | 179 | 32 | int:YWHAG |
| Interaction | WDR76 interactions | VIM MYH10 KRT18 COPB1 DSP SMC1A MCC LAMA5 LAMB2 IKZF1 TRRAP TRIP12 LMNA PLEC GCN1 DYNC1I2 PCNA | 5.98e-08 | 383 | 179 | 17 | int:WDR76 |
| Interaction | NPHP4 interactions | ANKRD13B VIM KRT10 MYH10 KRT17 DSP CNTRL GFAP ANGPTL6 OSR1 PLEC MUC5AC GOLGB1 | 2.00e-07 | 236 | 179 | 13 | int:NPHP4 |
| Interaction | KRT84 interactions | 2.43e-07 | 49 | 179 | 7 | int:KRT84 | |
| Interaction | MYH9 interactions | VIM MYH10 MYH11 NTRK1 ARFGEF1 UFL1 CHD3 ACE CCDC57 TRRAP NEFH MISP RNF123 ARRB1 LMNA CEP250 NCAPD2 PEX5 MACF1 PLEC FLOT1 DYNC1I2 LRRFIP2 | 2.54e-07 | 754 | 179 | 23 | int:MYH9 |
| Interaction | FGD5 interactions | KRT10 MYH10 MYH11 KRT17 KRT18 TRRAP JMJD6 MACF1 PLEC FLOT1 PCNA LRRFIP2 | 3.46e-07 | 207 | 179 | 12 | int:FGD5 |
| Interaction | INA interactions | 4.32e-07 | 173 | 179 | 11 | int:INA | |
| Interaction | GAN interactions | VIM KRT10 KRT17 KRT27 TRRAP GFAP TBCB NEFH NEFL MRPS26 PLEC CROCC MUC5AC | 4.44e-07 | 253 | 179 | 13 | int:GAN |
| Interaction | EED interactions | VIM KRT10 MYH10 MYH11 STAG1 KRT18 COPB1 DSP NSF SMC1A CAPNS1 NUP98 LAMA5 CHD3 XPNPEP1 TRRAP TRIP12 LIN9 SEC24C LMNA CGN MAD1L1 NCAPD2 UBA6 MACF1 RABGEF1 CGNL1 PLEC CROCC SNRPA1 FLOT1 PCNA LRRFIP2 | 4.57e-07 | 1445 | 179 | 33 | int:EED |
| Interaction | YWHAH interactions | TANC2 VIM MYH11 AMER1 CDC42BPA KRT18 NDE1 DSP EXPH5 NTRK1 CNTRL CAPNS1 USP43 TRIP12 NSD3 TBCB FRMD4A ARRB1 CGN MAD1L1 OTUD7A ANKRD11 MACF1 RABGEF1 CGNL1 PLEC LRBA RUBCN | 4.83e-07 | 1102 | 179 | 28 | int:YWHAH |
| Interaction | KCTD13 interactions | TANC2 KRT72 VIM KRT10 MYH10 MYH11 ANK2 ANK3 COPB1 MAP6 DSP NSF DOCK8 RAPGEF4 NBEA CHD3 GFAP KAT7 NEFH NEFL MISP SEC24C LMNA MACF1 CGNL1 PLEC CROCC FLOT1 DAGLA PCNA LRRFIP2 DNAH11 | 6.29e-07 | 1394 | 179 | 32 | int:KCTD13 |
| Interaction | KCNA3 interactions | VIM CDC42BPA ANK2 ANK3 COPB1 DSP NSF MYH7B EXPH5 SMC1A XPNPEP1 SEC24C MAP4K5 CGN NCAPD2 UBA6 ROBO1 MACF1 CARD11 EIF2AK4 LRBA SNRPA1 GCN1 GOLGB1 | 8.50e-07 | 871 | 179 | 24 | int:KCNA3 |
| Interaction | KRT72 interactions | 8.96e-07 | 59 | 179 | 7 | int:KRT72 | |
| Interaction | KRT6A interactions | 1.71e-06 | 160 | 179 | 10 | int:KRT6A | |
| Interaction | HDAC1 interactions | ANKRD13B RABEP2 VIM MYH10 CDC42BPA STAG1 SMC1A NUP98 USP43 ARFGEF1 IKZF1 CHD3 MCCC1 LIN9 RNF123 SATB1 CEP250 MAD1L1 NR2E1 NCAPD2 PLEC LRBA CROCC GCN1 GPRASP2 GOLGB1 PCNA | 1.77e-06 | 1108 | 179 | 27 | int:HDAC1 |
| Interaction | YWHAZ interactions | TANC2 VIM MYH10 MYH11 CDC42BPA KRT17 KRT18 COPB1 NDE1 MAP6 NSF EXPH5 NTRK1 SMC1A CAPNS1 USP43 MCC UFL1 TRIP12 GFAP MAP3K4 NEFL ARRB1 LMNA CGN MACF1 RABGEF1 CGNL1 PLEC RUBCN | 1.80e-06 | 1319 | 179 | 30 | int:YWHAZ |
| Interaction | YWHAQ interactions | TANC2 VIM MYH11 CDC42BPA KRT17 KRT18 NDE1 EXPH5 NTRK1 CAPNS1 USP43 UFL1 MCCC1 TRIP12 ARRB1 LMNA CEP250 CGN OTUD7A MACF1 RABGEF1 CGNL1 PLEC LRBA GCN1 GOLGB1 DYNC1I2 | 2.09e-06 | 1118 | 179 | 27 | int:YWHAQ |
| Interaction | KRT8 interactions | KRT72 VIM KRT10 KRT17 KRT18 DSP KRT27 TTLL5 ARFGEF1 CHD3 GFAP NEFL PEX5 PLEC KRT25 ALG13 | 2.15e-06 | 441 | 179 | 16 | int:KRT8 |
| Interaction | CDC5L interactions | AKAP6 TANC2 VIM KRT18 COPB1 DSP NSF DOCK8 NTRK1 SMC1A BMS1 UFL1 CHD3 SEC24C LMNA MAD1L1 NCAPD2 MACF1 TNFAIP2 PLEC SNRPA1 GCN1 GOLGB1 | 2.20e-06 | 855 | 179 | 23 | int:CDC5L |
| Interaction | KRT77 interactions | 2.26e-06 | 96 | 179 | 8 | int:KRT77 | |
| Interaction | SNAPIN interactions | KRT10 CDC42BPA KRT17 KRT27 SNAP23 KAT7 MYPOP MACF1 RABGEF1 PLEC | 2.81e-06 | 169 | 179 | 10 | int:SNAPIN |
| Interaction | LZTS2 interactions | VIM ANK3 COPB1 NDE1 DSP EXPH5 BMS1 ODF2 GFAP CEP250 CGN RBFOX1 ANKRD11 CGNL1 FLOT1 PPP1R16A ALG13 | 3.38e-06 | 512 | 179 | 17 | int:LZTS2 |
| Interaction | KRT6C interactions | 5.06e-06 | 76 | 179 | 7 | int:KRT6C | |
| Interaction | KRT7 interactions | 7.14e-06 | 80 | 179 | 7 | int:KRT7 | |
| Interaction | NEFM interactions | 7.96e-06 | 190 | 179 | 10 | int:NEFM | |
| Interaction | KRT19 interactions | KRT72 VIM KRT10 KRT17 KRT18 DSP TTLL5 CHD3 GFAP RNF123 PLEC DYNC1I2 | 8.69e-06 | 282 | 179 | 12 | int:KRT19 |
| Interaction | KRT76 interactions | 9.87e-06 | 84 | 179 | 7 | int:KRT76 | |
| Interaction | EFNA4 interactions | VIM KRT10 H3-5 KRT17 DSP CNTRL UFL1 GFAP RNF123 TIMELESS LRBA | 9.99e-06 | 239 | 179 | 11 | int:EFNA4 |
| Interaction | APC interactions | MYH10 MYH11 AMER1 KRT17 KRT18 EXPH5 NUP98 CEP250 MAD1L1 ARL13B MACF1 CGNL1 FLOT1 PCNA | 1.04e-05 | 389 | 179 | 14 | int:APC |
| Interaction | DES interactions | 1.21e-05 | 158 | 179 | 9 | int:DES | |
| Interaction | HOOK3 interactions | 1.36e-05 | 202 | 179 | 10 | int:HOOK3 | |
| Interaction | CCDC138 interactions | 1.43e-05 | 123 | 179 | 8 | int:CCDC138 | |
| Interaction | PRPH interactions | 1.48e-05 | 204 | 179 | 10 | int:PRPH | |
| Interaction | NINL interactions | NDE1 DSP TTLL5 ODF2 ACE CCDC57 KAT7 LMNA CEP20 MRPS26 CEP250 MAD1L1 CGNL1 DYNC1I2 PCNA | 1.53e-05 | 458 | 179 | 15 | int:NINL |
| Interaction | CEP126 interactions | 1.67e-05 | 91 | 179 | 7 | int:CEP126 | |
| Interaction | OBSL1 interactions | H3-5 KRT17 KRT18 DSP SMC1A NUP98 LAMA5 TRRAP TRIP12 NEFL MISP SEC24C LMNA CGN MACF1 PLEC SNRPA1 FLOT1 GCN1 GPRASP2 GOLGB1 PCNA | 1.74e-05 | 902 | 179 | 22 | int:OBSL1 |
| Interaction | AGAP2 interactions | 1.90e-05 | 210 | 179 | 10 | int:AGAP2 | |
| Interaction | MOB3C interactions | COPB1 DSP NSF SMC1A UFL1 TRIP12 CGN NCAPD2 ROBO1 SNRPA1 GCN1 DYNC1I2 PCNA | 2.36e-05 | 364 | 179 | 13 | int:MOB3C |
| Interaction | KRT6B interactions | 2.39e-05 | 132 | 179 | 8 | int:KRT6B | |
| Interaction | WAPL interactions | 2.50e-05 | 173 | 179 | 9 | int:WAPL | |
| Interaction | NEIL3 interactions | 2.54e-05 | 97 | 179 | 7 | int:NEIL3 | |
| Interaction | CHMP4B interactions | VIM MYH10 MYH11 H3-5 DSP BMS1 NUP98 GFAP NEFL MISP RNF123 LMNA JMJD6 GNAL PLEC SNRPA1 FLOT1 GCN1 GOLGB1 | 2.67e-05 | 727 | 179 | 19 | int:CHMP4B |
| Interaction | CTNNB1 interactions | TANC2 MYH10 AMER1 ANK2 ANK3 NTRK1 NUP98 USP43 SNAP23 ARFGEF1 PTPRU CBFB TRRAP SEC24C LMNA SATB1 CEP250 CGNL1 CROCC FLOT1 CDH6 PCNA LRRFIP2 | 3.20e-05 | 1009 | 179 | 23 | int:CTNNB1 |
| Interaction | TJP1 interactions | VIM KRT10 NTRK1 CNTRL ODF2 CGN ARL13B OTUD7A CGNL1 PLEC FLOT1 LRRFIP2 | 3.54e-05 | 325 | 179 | 12 | int:TJP1 |
| Interaction | CASP6 interactions | 3.70e-05 | 70 | 179 | 6 | int:CASP6 | |
| Interaction | CWF19L2 interactions | 3.73e-05 | 182 | 179 | 9 | int:CWF19L2 | |
| Interaction | SNW1 interactions | VIM STAG1 COPB1 DSP NSF NTRK1 SMC1A UFL1 IKZF1 CHD3 ODF2 TRIP12 MISP LMNA MAD1L1 NCAPD2 PLEC SNRPA1 GCN1 | 3.86e-05 | 747 | 179 | 19 | int:SNW1 |
| Interaction | CFTR interactions | AKAP6 KRT72 VIM KRT10 MYH10 MYH11 KRT17 KRT18 COPB1 DSP MYH7B CAPNS1 SNAP23 LAMA5 MCCC1 TRIP12 MISP SEC24C LMNA CGN NCAPD2 MACF1 PLEC LRBA FLOT1 GCN1 DYNC1I2 PCNA LRRFIP2 | 4.58e-05 | 1480 | 179 | 29 | int:CFTR |
| Interaction | ACE2 interactions | VIM KRT10 MYH10 KRT17 KRT18 COPB1 DSP EXPH5 SMC1A BMS1 NUP98 LAMA5 NBEA CHD3 PTPRU GFAP TBCB ARRB1 LMNA ARL13B NCAPD2 PLEC GCN1 GOLGB1 | 4.66e-05 | 1106 | 179 | 24 | int:ACE2 |
| Interaction | YWHAE interactions | TANC2 VIM MYH10 MYH11 CDC42BPA KRT18 NDE1 DOCK8 EXPH5 NTRK1 CAPNS1 USP43 MCC UFL1 TRIP12 TBCB FRMD4A ARRB1 CEP250 CGN MACF1 CGNL1 LRBA RUBCN DYNC1I2 LRRFIP2 | 4.83e-05 | 1256 | 179 | 26 | int:YWHAE |
| Interaction | STX6 interactions | CDC42BPA ANK3 NSF SNAP23 ARFGEF1 NAPG NBEA VIPAS39 LMNA ARL13B ROBO1 MACF1 LRBA GOLGB1 | 4.94e-05 | 448 | 179 | 14 | int:STX6 |
| Interaction | GFAP interactions | 5.14e-05 | 236 | 179 | 10 | int:GFAP | |
| Interaction | DCPS interactions | KRT10 MYH10 COPB1 NTRK1 SMC1A CAPNS1 BMS1 NUP98 IKZF1 TRIP12 CEP250 PLEC SNRPA1 | 5.34e-05 | 394 | 179 | 13 | int:DCPS |
| Interaction | KRT1 interactions | 5.52e-05 | 238 | 179 | 10 | int:KRT1 | |
| Interaction | KRT14 interactions | 5.65e-05 | 192 | 179 | 9 | int:KRT14 | |
| Interaction | KRT5 interactions | 5.88e-05 | 193 | 179 | 9 | int:KRT5 | |
| Interaction | HOOK1 interactions | 5.92e-05 | 240 | 179 | 10 | int:HOOK1 | |
| Interaction | TSPOAP1 interactions | 6.58e-05 | 25 | 179 | 4 | int:TSPOAP1 | |
| Interaction | OFD1 interactions | KRT18 NDE1 DSP NTRK1 TTLL5 CNTRL ODF2 CCDC57 TRRAP CEP20 SLMAP FLOT1 | 6.66e-05 | 347 | 179 | 12 | int:OFD1 |
| Interaction | PER2 interactions | 6.86e-05 | 153 | 179 | 8 | int:PER2 | |
| Interaction | RALBP1 interactions | 7.17e-05 | 198 | 179 | 9 | int:RALBP1 | |
| Interaction | ATOH1 interactions | 7.87e-05 | 80 | 179 | 6 | int:ATOH1 | |
| Interaction | AGR2 interactions | VIM KRT10 MYH10 MYH11 ANK3 COPB1 DSP CNTRL CAPNS1 XPNPEP1 MCCC1 ACE LMNA RBFOX1 ANKRD11 MACF1 PLEC LRBA GCN1 MUC5AC ALG13 | 8.79e-05 | 934 | 179 | 21 | int:AGR2 |
| Interaction | HDAC2 interactions | KRT10 MYH10 KRT17 STAG1 COPB1 NSF NTRK1 SMC1A USP43 UFL1 IKZF1 CHD3 MCCC1 LIN9 LMNA SATB1 MAD1L1 NR2E1 NCAPD2 LRBA | 8.97e-05 | 865 | 179 | 20 | int:HDAC2 |
| Interaction | DENND6A interactions | 9.67e-05 | 83 | 179 | 6 | int:DENND6A | |
| Interaction | NEFL interactions | 9.80e-05 | 161 | 179 | 8 | int:NEFL | |
| Interaction | FBXO22 interactions | RABEP2 ANK3 EXPH5 RAPGEF4 NBEA CCDC57 TRRAP TRIP12 MAP3K4 TRANK1 NCAPD2 ANKRD11 UBA6 EIF2AK4 LRBA | 1.00e-04 | 540 | 179 | 15 | int:FBXO22 |
| Interaction | CFAP184 interactions | 1.02e-04 | 162 | 179 | 8 | int:CFAP184 | |
| Interaction | PEX5L interactions | 1.16e-04 | 54 | 179 | 5 | int:PEX5L | |
| Interaction | SPATA2 interactions | 1.26e-04 | 87 | 179 | 6 | int:SPATA2 | |
| Interaction | EZR interactions | CDC42BPA ANK2 ANK3 NTRK1 MCC SNAP23 NBEA XPNPEP1 PRX MISP MACF1 LRBA CROCC GOLGB1 DYNC1I2 | 1.30e-04 | 553 | 179 | 15 | int:EZR |
| Interaction | SCYL1 interactions | 1.37e-04 | 169 | 179 | 8 | int:SCYL1 | |
| Interaction | SLFN11 interactions | VIM MYH10 MYH11 MYH7B SMC1A NUP98 LAMA5 CHD3 TRRAP TRIP12 LMNA SNRPA1 | 1.42e-04 | 376 | 179 | 12 | int:SLFN11 |
| Interaction | KXD1 interactions | 1.43e-04 | 170 | 179 | 8 | int:KXD1 | |
| Interaction | DNAH3 interactions | 1.43e-04 | 12 | 179 | 3 | int:DNAH3 | |
| Interaction | DSCAM interactions | 1.49e-04 | 171 | 179 | 8 | int:DSCAM | |
| Interaction | TWF1 interactions | 1.55e-04 | 172 | 179 | 8 | int:TWF1 | |
| Interaction | KRT23 interactions | 1.57e-04 | 31 | 179 | 4 | int:KRT23 | |
| Interaction | ALK interactions | 1.61e-04 | 271 | 179 | 10 | int:ALK | |
| Interaction | TEAD2 interactions | 1.64e-04 | 130 | 179 | 7 | int:TEAD2 | |
| Interaction | GML interactions | 1.64e-04 | 58 | 179 | 5 | int:GML | |
| Interaction | OTUD7A interactions | 1.64e-04 | 58 | 179 | 5 | int:OTUD7A | |
| Interaction | TRIM37 interactions | VIM KRT10 MYH10 KRT18 COPB1 DSP TTLL5 MAGEB18 LMNA CEP250 ANKRD11 PEX5 CARD11 PLEC PCNA LRRFIP2 | 1.64e-04 | 630 | 179 | 16 | int:TRIM37 |
| Interaction | C6orf141 interactions | 1.71e-04 | 92 | 179 | 6 | int:C6orf141 | |
| Interaction | SCAF8 interactions | 1.78e-04 | 59 | 179 | 5 | int:SCAF8 | |
| Interaction | NAB2 interactions | 1.88e-04 | 133 | 179 | 7 | int:NAB2 | |
| Interaction | KIF15 interactions | 1.93e-04 | 94 | 179 | 6 | int:KIF15 | |
| Interaction | PHLPP1 interactions | KRT18 COPB1 DSP NUP98 CHD3 MISP ROBO1 PLEC SNRPA1 GCN1 GOLGB1 | 2.00e-04 | 333 | 179 | 11 | int:PHLPP1 |
| Interaction | FN1 interactions | VIM KRT10 MYH10 KRT18 COPB1 TMED5 CAPNS1 SNAP23 NAPG ITIH1 RNF123 SEC24C LMNA MACF1 PLEC LRBA FLOT1 GCN1 PCNA | 2.03e-04 | 848 | 179 | 19 | int:FN1 |
| Interaction | ALB interactions | KRT10 KRT17 SMC1A LAMA5 UFL1 IKZF1 CHD3 TRRAP GFAP ITIH1 RNF123 GCN1 | 2.04e-04 | 391 | 179 | 12 | int:ALB |
| Interaction | IVNS1ABP interactions | 2.11e-04 | 180 | 179 | 8 | int:IVNS1ABP | |
| Interaction | FAM167A interactions | 2.16e-04 | 96 | 179 | 6 | int:FAM167A | |
| Interaction | SIPA1L2 interactions | 2.16e-04 | 136 | 179 | 7 | int:SIPA1L2 | |
| Interaction | HAUS5 interactions | 2.16e-04 | 136 | 179 | 7 | int:HAUS5 | |
| Interaction | CBL interactions | VIM KRT10 MYH10 WAS KRT17 KRT18 NTRK1 SNAP23 ITGA6 CBFB LMNA RABGEF1 GNAL FLOT1 | 2.18e-04 | 516 | 179 | 14 | int:CBL |
| Interaction | PRICKLE2 interactions | 2.25e-04 | 62 | 179 | 5 | int:PRICKLE2 | |
| Interaction | KRT4 interactions | 2.25e-04 | 62 | 179 | 5 | int:KRT4 | |
| Cytoband | 16p13.11 | 1.01e-04 | 23 | 181 | 3 | 16p13.11 | |
| Cytoband | 17q21.2 | 1.75e-04 | 70 | 181 | 4 | 17q21.2 | |
| GeneFamily | Keratins, type I | 9.09e-07 | 28 | 117 | 5 | 608 | |
| GeneFamily | Myosin heavy chains | 2.15e-06 | 15 | 117 | 4 | 1098 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.44e-05 | 8 | 117 | 3 | 939 | |
| GeneFamily | Intermediate filaments Type III | 4.10e-04 | 5 | 117 | 2 | 610 | |
| GeneFamily | Intermediate filaments Type IV | 6.12e-04 | 6 | 117 | 2 | 611 | |
| GeneFamily | Ankyrin repeat domain containing | 1.00e-03 | 242 | 117 | 7 | 403 | |
| GeneFamily | Cohesin complex | 1.13e-03 | 8 | 117 | 2 | 1060 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 1.45e-03 | 9 | 117 | 2 | 1230 | |
| GeneFamily | Transmembrane p24 trafficking proteins | 1.81e-03 | 10 | 117 | 2 | 1064 | |
| GeneFamily | Laminin subunits | 2.63e-03 | 12 | 117 | 2 | 626 | |
| GeneFamily | OTU domain containing | 5.30e-03 | 17 | 117 | 2 | 669 | |
| Coexpression | GSE20500_RETINOIC_ACID_VS_RARA_ANTAGONIST_TREATED_CD4_TCELL_DN | COPB1 MYH7B CNTRL TSPYL1 ODF2 ACTL8 JMJD6 MAD1L1 UBA6 MUC5AC ALG13 | 1.34e-07 | 198 | 180 | 11 | M7708 |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-secretory_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | CDC42BPA USP43 ITGA6 LAMB2 NBEA PTPRU MISP MAP4K5 CGN MUC5AC | 8.69e-09 | 197 | 181 | 10 | d6c9da7a3a6d2bcb13e2fc6605c8a59e7fb121c5 |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | CDC42BPA USP43 ITGA6 LAMB2 NBEA PTPRU MISP MAP4K5 CGN MUC5AC | 8.69e-09 | 197 | 181 | 10 | 80b05c8ad9c1edc5dea3236079372475431343fe |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | TANC2 CDC42BPA ARFGEF1 NAPG NSD3 TMTC3 MAP4K5 ANKRD11 GOLGB1 LRRFIP2 | 9.57e-09 | 199 | 181 | 10 | c425e7975f492ed5cfcca022248adb627e1d27d4 |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.00e-08 | 200 | 181 | 10 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital|World / Primary Cells by Cluster | 1.00e-08 | 200 | 181 | 10 | 6bbe8e1f3e91678f1bfb14945365c1578a59a604 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital-19|World / Primary Cells by Cluster | 1.00e-08 | 200 | 181 | 10 | c831d9e0a7178e3634da45548f91fa9e8dc6557c | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.33e-08 | 179 | 181 | 9 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.14e-08 | 182 | 181 | 9 | 1aea96ee211f7b9caef7fd385233f51be6021a73 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.14e-08 | 182 | 181 | 9 | b427e43ee523a3ea9eca3207f3d82042f10f022a | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.14e-08 | 182 | 181 | 9 | c0f63cfc67d61c0877b7acb2946dfb35aae8a8f5 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.14e-08 | 182 | 181 | 9 | 4cb182ef39be2044a6ad7266f332d4177591e550 | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-CD4+_T_activated|COVID-19_Mild / Disease group, lineage and cell class | 6.44e-08 | 183 | 181 | 9 | 7717fce227b4e02ed41baad8ae7dd2e22bd7c13e | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | TANC2 CDC42BPA CNTRL NAPG TRIP12 TMTC3 MAP4K5 ANKRD11 GOLGB1 | 1.32e-07 | 199 | 181 | 9 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster | 1.32e-07 | 199 | 181 | 9 | 1b1bccf4293f11048709d15a3c892c0edf3da3d2 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster | 1.32e-07 | 199 | 181 | 9 | 4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer|World / Primary Cells by Cluster | 1.37e-07 | 200 | 181 | 9 | db10f76938af553d1a2275bb02ef75dff3c3135b | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer-21|World / Primary Cells by Cluster | 1.37e-07 | 200 | 181 | 9 | 30a3e4aee12ec1b5acdce90f86c9733c27a7f6fc | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 8.98e-07 | 184 | 181 | 8 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | facs-Trachea-nan-3m-Epithelial-basal_epithelial_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-06 | 187 | 181 | 8 | fe9fc21192ede2eea61f419d20ccda254569d0a6 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.10e-06 | 189 | 181 | 8 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | IPF-Epithelial-Basal|IPF / Disease state, Lineage and Cell class | 1.14e-06 | 190 | 181 | 8 | ea19e9ce954f2dfde97388db9695325cd92ab88f | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 1.14e-06 | 190 | 181 | 8 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | IPF-Epithelial-Basal|World / Disease state, Lineage and Cell class | 1.24e-06 | 192 | 181 | 8 | 9b91e0b162e6f3ce86dd15cc33c2e745d069581f | |
| ToppCell | wk_08-11-Epithelial-Airway_epithelial_progenitor-epi-airway_progenitor_early|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.50e-06 | 197 | 181 | 8 | 4ae08ccb6f1da626c4f0fb0140a2811cb6e31ba1 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.56e-06 | 198 | 181 | 8 | d0ecace1fad24ce50b0935036fabb07e6c9e372d | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 1.56e-06 | 198 | 181 | 8 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Late_airway_progenitor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.62e-06 | 199 | 181 | 8 | 494461665f945ce6c97299c58f7785e90dec5812 | |
| ToppCell | Bronchial_Biopsy-Epithelial|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.62e-06 | 199 | 181 | 8 | ef5d8917c8d011184830a0b8197afc6266707b37 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.68e-06 | 200 | 181 | 8 | 9169a9ec8e9ab95d90a64c5a19ac666a5cf82313 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Mild / Disease, condition lineage and cell class | 1.68e-06 | 200 | 181 | 8 | d9e8a0d047d4403fb7265fde7448e23a7780785c | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte|LPS_only / Treatment groups by lineage, cell group, cell type | 1.68e-06 | 200 | 181 | 8 | 8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_only / Treatment groups by lineage, cell group, cell type | 1.68e-06 | 200 | 181 | 8 | 69edc375d85689300d1dbc1217fedc40063ecdcb | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.68e-06 | 200 | 181 | 8 | f5bc7d30aa03dd0f95eb64255bd1a2543be8d327 | |
| ToppCell | E17.5-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.75e-06 | 150 | 181 | 7 | 201d5b68e71c6c003285428be96c488e6d526edf | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.57e-06 | 156 | 181 | 7 | abf9dd075b1ca8f613c660cc82f8a5af071fb6ab | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.57e-06 | 156 | 181 | 7 | dd41ed918b07fa248da458a629b3c53cb7ea8764 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-Lymphoid_DC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.59e-06 | 167 | 181 | 7 | 8b223333c0c7a85b5a1af6f2f5b12ee0d94357f6 | |
| ToppCell | COPD-Epithelial-Aberrant_Basaloid|World / Disease state, Lineage and Cell class | 8.18e-06 | 177 | 181 | 7 | 22b7cda748cf5e665be54ca5bae89f0c130d5e7f | |
| ToppCell | droplet-Skin-nan-18m-Lymphocytic-T_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.49e-06 | 178 | 181 | 7 | e0769ad06f92423a3cb6c78a61da3ba5bd9b4eae | |
| ToppCell | Club_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 8.49e-06 | 178 | 181 | 7 | be64d4be23fb96a4cdd7980c58880fdfe817747f | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.49e-06 | 178 | 181 | 7 | 431e7557b8e8764e16e9e48368ce6bfa3c61561a | |
| ToppCell | droplet-Skin-nan-18m-Lymphocytic-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.49e-06 | 178 | 181 | 7 | 12d5c6be6cfbf733e3cb02780606b3725eda7d2b | |
| ToppCell | droplet-Skin-nan-18m-Lymphocytic|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.49e-06 | 178 | 181 | 7 | 11c2ce093b7538518c8d4497dc5b0b4da22bf1a8 | |
| ToppCell | Control-Epithelial-Basal|Control / Disease state, Lineage and Cell class | 9.81e-06 | 182 | 181 | 7 | caddd0a52f0234ea6a916186ffaf2454cdcd80ee | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-05 | 183 | 181 | 7 | 26b18d1cc5d98f185176e100bafb9bc9081c66f7 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.09e-05 | 185 | 181 | 7 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | facs-Trachea-3m-Epithelial-airway_epithelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.13e-05 | 186 | 181 | 7 | 37b93ebd64ebbd08193a746e5bc9b350c2570733 | |
| ToppCell | AT1_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.17e-05 | 187 | 181 | 7 | f1dda349335e08dbfc8395d373924037f5ad2fd6 | |
| ToppCell | IPF-Epithelial-Aberrant_Basaloid|IPF / Disease state, Lineage and Cell class | 1.17e-05 | 187 | 181 | 7 | 19d6a404fc3651d98a93e3848e372df51a239c57 | |
| ToppCell | facs-Trachea-3m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.21e-05 | 188 | 181 | 7 | 137ed9958044fab7a13648affb469585d1c48cf6 | |
| ToppCell | facs-Trachea-3m-Epithelial-airway_epithelial-respiratory_basal_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.21e-05 | 188 | 181 | 7 | 8ffb5394f7b00ea483a5fe4df894d22fda935e5c | |
| ToppCell | IPF-Epithelial-Aberrant_Basaloid|World / Disease state, Lineage and Cell class | 1.25e-05 | 189 | 181 | 7 | 8030a353473da34ae92429f2d822171a2e94248f | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.30e-05 | 190 | 181 | 7 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.30e-05 | 190 | 181 | 7 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.39e-05 | 192 | 181 | 7 | d6f656be2698bd215717d35f4e7ab727c08c61e0 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 1.39e-05 | 192 | 181 | 7 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.39e-05 | 192 | 181 | 7 | b73f24d1c55dfef1eb01c26da117dbf637ea080a | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.39e-05 | 192 | 181 | 7 | 450baeb5c3df7a9445472530002ce38f177a333c | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-basal_bladder_epithelial_cell_(Krt5+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-05 | 193 | 181 | 7 | 268925bfe85fb94a93a4ff8fe078d692df888140 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.43e-05 | 193 | 181 | 7 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-bladder_urothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-05 | 193 | 181 | 7 | ee91a796d0f6d4cee7a93a525689e716fdceeda5 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Epithelial-luminal_progenitor_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-05 | 194 | 181 | 7 | 550e61a40be2baa59520aaf5912bb99ad094ba15 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.48e-05 | 194 | 181 | 7 | 7b2b40a56eb9c7203ca50133b2da4fd8fdd4a5cf | |
| ToppCell | 11.5-Airway-Epithelial-Secretory_progenitor|Airway / Age, Tissue, Lineage and Cell class | 1.53e-05 | 195 | 181 | 7 | 8cbc78a6cb812f907c69b00f85263976216840ac | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-05 | 195 | 181 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-05 | 195 | 181 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.53e-05 | 195 | 181 | 7 | 22191d361af136942508f1553ff41a626ed982ad | |
| ToppCell | Outlier-Outlier|World / Primary Cells by Cluster | 1.59e-05 | 196 | 181 | 7 | c1d0f8e77a75cbd04d1df18ae7162ac463acfc4c | |
| ToppCell | Outlier-Outlier-Outlier-Outlier|World / Primary Cells by Cluster | 1.59e-05 | 196 | 181 | 7 | 2a6ee499cbedcc1ffeb94739d3498207661add33 | |
| ToppCell | Outlier|World / Primary Cells by Cluster | 1.59e-05 | 196 | 181 | 7 | 62f121878334afa43af60cedcb785035d19caff2 | |
| ToppCell | Outlier-Outlier-Outlier|World / Primary Cells by Cluster | 1.59e-05 | 196 | 181 | 7 | 875fc18ca52633f1a53fd17ffeafc59803aec97d | |
| ToppCell | Outlier-Outlier-Outlier-Outlier-32|World / Primary Cells by Cluster | 1.59e-05 | 196 | 181 | 7 | 433ee89d5451d14a42a4c54b85006bd71884486a | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type | 1.59e-05 | 196 | 181 | 7 | 4ac4073380d939a73cec7413e9f3f5ef616d2924 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-05 | 197 | 181 | 7 | f4dad4423384a2a25e064c849ffccf2811573be0 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.64e-05 | 197 | 181 | 7 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.64e-05 | 197 | 181 | 7 | fd43fc1cbf0c17b370397d73dddc572565a759c7 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 1.69e-05 | 198 | 181 | 7 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 1.69e-05 | 198 | 181 | 7 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.69e-05 | 198 | 181 | 7 | dac7b68bb8f1c4d8aa7fdfada61f79956866e874 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.69e-05 | 198 | 181 | 7 | 9a12e5e47236433e512c668005fe3f8be6fde95c | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 1.75e-05 | 199 | 181 | 7 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV-2|World / Primary Cells by Cluster | 1.75e-05 | 199 | 181 | 7 | f09b40245d3d826275bbe5f508dedccc75a911bd | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.75e-05 | 199 | 181 | 7 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV|World / Primary Cells by Cluster | 1.75e-05 | 199 | 181 | 7 | e45448ec4db8875c8aaa9aad109a10e2905a4226 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-Pericytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.75e-05 | 199 | 181 | 7 | f1723cfd6fbb8c8903a3b167872ec8523e3be250 | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 1.75e-05 | 199 | 181 | 7 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | normal_Pleural_Fluid-Epithelial_cells|normal_Pleural_Fluid / Location, Cell class and cell subclass | 1.75e-05 | 199 | 181 | 7 | 564ba7acd03be2d6e4d0850cb2c7237a788dc275 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_|World / Primary Cells by Cluster | 1.75e-05 | 199 | 181 | 7 | 058373b4ac3cec2108cb24265628ff0a50646e33 | |
| ToppCell | Bronchial-10x5prime-Epithelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.81e-05 | 200 | 181 | 7 | d3ee5f79513e2ac02ad3329b59e6290d457c44d2 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.81e-05 | 200 | 181 | 7 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.81e-05 | 200 | 181 | 7 | c06426f877919bdd267ea2fd7e7973c6619832ae | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.81e-05 | 200 | 181 | 7 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Intermediate|2m / Sample Type, Dataset, Time_group, and Cell type. | 1.81e-05 | 200 | 181 | 7 | 2a635694844ddabcd98462c5636a6f41a3f08a46 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Macroglial|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 1.81e-05 | 200 | 181 | 7 | be1abe5bb1ce4e7dfec63af4ed0fc5b96bf77866 | |
| ToppCell | NS-control-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.81e-05 | 200 | 181 | 7 | d014959891893b6d3854a471fba1dc50c6625a0a | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.81e-05 | 200 | 181 | 7 | e1da1b15d2ca06796ee1ab7cef586ae0b4dc0a0a | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.81e-05 | 200 | 181 | 7 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | LPS-IL1RA+antiTNF-Unknown-Endothelial-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.00e-05 | 154 | 181 | 6 | 16fdafb5c64d2db321554f87129a962d113f1668 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.46e-05 | 157 | 181 | 6 | bfec34182f052cf1c0d847ba53ea335d4d1190de | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.62e-05 | 158 | 181 | 6 | e7db0ee4740e3c7a4d97d7cd7462e2c2ab458a4b | |
| Computational | Genes in the cancer module 68. | 6.48e-06 | 26 | 113 | 5 | MODULE_68 | |
| Computational | Keratin. | 1.45e-04 | 26 | 113 | 4 | MODULE_298 | |
| Drug | 1-phenylpentan-3-amine | 2.31e-09 | 29 | 180 | 7 | CID005195771 | |
| Drug | AC1L9IK6 | 1.72e-07 | 32 | 180 | 6 | CID000445780 | |
| Drug | nocodazole | VIM MYH10 MYH11 KRT18 COPB1 NDE1 MAP6 MYH7B MCC ARFGEF1 GRAMD4 ACTL8 LMNA MAD1L1 PCMTD2 GOLGB1 DYNC1I2 | 2.66e-07 | 477 | 180 | 17 | CID000004122 |
| Drug | isoproterenol | AKAP6 VIM NPR2 MYH10 MYH11 ANK2 NSF MYH7B EXPH5 ACE GFAP ARRB1 ACTL8 BEST4 LPL CARD11 GNAL TNFAIP2 LRBA DAGLA | 3.76e-07 | 669 | 180 | 20 | CID000003779 |
| Drug | diphenylditelluride | 1.78e-06 | 12 | 180 | 4 | ctd:C434247 | |
| Drug | Z-Gly-phe-NH2 | 2.56e-06 | 13 | 180 | 4 | CID000096819 | |
| Drug | plakin | 3.96e-06 | 82 | 180 | 7 | CID000018752 | |
| Drug | Ornidazole [16773-42-5]; Up 200; 18.2uM; PC3; HT_HG-U133A | 4.37e-06 | 199 | 180 | 10 | 2109_UP | |
| Drug | AC1L9INI | 7.15e-06 | 59 | 180 | 6 | CID000445839 | |
| Drug | NSC613009 | 9.34e-06 | 130 | 180 | 8 | CID000003800 | |
| Drug | diphenyl ditelluride | 9.55e-06 | 6 | 180 | 3 | CID000100657 | |
| Drug | microcystin RR | 1.13e-05 | 96 | 180 | 7 | ctd:C063855 | |
| Drug | strontium chromate | 1.39e-05 | 99 | 180 | 7 | CID000024599 | |
| Drug | C-cluster | 1.52e-05 | 139 | 180 | 8 | CID000446537 | |
| Drug | chromium nitrate | 2.20e-05 | 43 | 180 | 5 | ctd:C041167 | |
| Drug | MAPS | 2.22e-05 | 191 | 180 | 9 | CID000066161 | |
| Drug | Propoxycaine hydrochloride [550-83-4]; Down 200; 12uM; MCF7; HT_HG-U133A | 2.61e-05 | 195 | 180 | 9 | 3583_DN | |
| Drug | FG 9041 | 2.64e-05 | 8 | 180 | 3 | ctd:C056723 | |
| Drug | AC1L1KMJ | VIM WAS ANK2 ANK3 MYH7B CAPNS1 LAMA5 LAMB2 ACTL8 JMJD6 CGN MACF1 PLEC LRBA | 2.74e-05 | 476 | 180 | 14 | CID000030956 |
| Drug | Pantothenic acid calcium salt monohydrate [63409-48-3]; Down 200; 8uM; HL60; HT_HG-U133A | 2.83e-05 | 197 | 180 | 9 | 1311_DN | |
| Drug | Bupivacaine hydrochloride [18010-40-7]; Up 200; 12.4uM; HL60; HT_HG-U133A | 2.83e-05 | 197 | 180 | 9 | 2404_UP | |
| Drug | 1pxm | 3.60e-05 | 78 | 180 | 6 | CID000447959 | |
| Drug | YIGSR | 3.87e-05 | 79 | 180 | 6 | CID000123977 | |
| Drug | Excitatory Amino Acid Antagonists | 3.94e-05 | 9 | 180 | 3 | ctd:D018691 | |
| Drug | bromfenacoum | VIM MYH10 MYH11 ANK3 MAP6 NSF NUP98 NAPG LAMB2 GRM4 GFAP NEFH NEFL LMNA MRPS26 MACF1 | 5.58e-05 | 644 | 180 | 16 | ctd:C013418 |
| Drug | OMDM-2 | 5.60e-05 | 10 | 180 | 3 | CID003906781 | |
| Drug | deserpidine | 6.22e-05 | 2 | 180 | 2 | CID000008550 | |
| Drug | NSC34533 | 6.75e-05 | 54 | 180 | 5 | CID000003512 | |
| Drug | VTCs | 6.75e-05 | 54 | 180 | 5 | CID000006413 | |
| Drug | 2C5P | 6.91e-05 | 127 | 180 | 7 | CID000447961 | |
| Drug | BM165 | 7.65e-05 | 11 | 180 | 3 | CID003352881 | |
| Drug | AC1NSPXR | 7.65e-05 | 11 | 180 | 3 | CID005313815 | |
| Drug | Reidispongiolide C | 7.97e-05 | 279 | 180 | 10 | CID005289285 | |
| Drug | NSC-194805 | 8.07e-05 | 90 | 180 | 6 | CID000303988 | |
| Drug | CK 6 | 9.53e-05 | 58 | 180 | 5 | CID000447960 | |
| Drug | Exiproben | 1.01e-04 | 12 | 180 | 3 | CID000018995 | |
| Drug | carbachol | NPR2 MYH10 MYH11 MYH7B LAMA5 LAMB2 GRM4 ORAI1 NUDT6 ACTL8 LPL CARD11 TIMELESS GNAL LRBA DAGLA | 1.20e-04 | 688 | 180 | 16 | CID000002551 |
| Drug | Px A | 1.29e-04 | 33 | 180 | 4 | CID003330140 | |
| Drug | Estradiol-17 beta [50-28-2]; Down 200; 14.6uM; PC3; HT_HG-U133A | 1.40e-04 | 190 | 180 | 8 | 6718_DN | |
| Drug | Vitamin K 3 | KRT10 ANK2 ANK3 NDE1 NTRK1 SMC1A BMS1 LAMA5 LAMB2 MCCC1 CBFB TRRAP FRMD4A NUDT6 RBFOX1 SLMAP ANKRD11 ROBO1 TIMELESS CGNL1 PCNA NSMCE4A PPP1R16A | 1.40e-04 | 1249 | 180 | 23 | ctd:D024483 |
| Drug | Zaprinast [37762-06-4]; Down 200; 14.8uM; PC3; HT_HG-U133A | 1.56e-04 | 193 | 180 | 8 | 6749_DN | |
| Drug | Procaine hydrochloride [51-05-8]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 1.56e-04 | 193 | 180 | 8 | 5430_DN | |
| Drug | Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; PC3; HT_HG-U133A | 1.61e-04 | 194 | 180 | 8 | 3725_DN | |
| Drug | Bendroflumethiazide [73-48-3]; Down 200; 9.4uM; PC3; HT_HG-U133A | 1.61e-04 | 194 | 180 | 8 | 3758_DN | |
| Drug | Pentamidine isethionate [140-64-7]; Up 200; 6.8uM; PC3; HT_HG-U133A | 1.61e-04 | 194 | 180 | 8 | 4573_UP | |
| Drug | sulfamethoxypyridazine | 1.63e-04 | 35 | 180 | 4 | CID000005330 | |
| Drug | Clopamide [636-54-4]; Up 200; 11.6uM; PC3; HT_HG-U133A | 1.67e-04 | 195 | 180 | 8 | 6301_UP | |
| Drug | 3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Up 200; 13.8uM; PC3; HT_HG-U133A | 1.67e-04 | 195 | 180 | 8 | 4298_UP | |
| Drug | (-) -Levobunolol hydrochloride [27912-14-7]; Up 200; 12.2uM; PC3; HT_HG-U133A | 1.67e-04 | 195 | 180 | 8 | 4016_UP | |
| Drug | Atractyloside potassium salt [102130-43-8]; Up 200; 5uM; MCF7; HT_HG-U133A | 1.73e-04 | 196 | 180 | 8 | 3435_UP | |
| Drug | Cotinine (-) [486-56-6]; Down 200; 22.6uM; MCF7; HT_HG-U133A | 1.73e-04 | 196 | 180 | 8 | 1511_DN | |
| Drug | Benzonatate [104-31-4]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 1.73e-04 | 196 | 180 | 8 | 1679_DN | |
| Drug | Morantel tartrate [26155-31-7]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 1.73e-04 | 196 | 180 | 8 | 7010_UP | |
| Drug | Diphemanil methylsulfate [62-97-5]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 1.73e-04 | 196 | 180 | 8 | 1494_DN | |
| Drug | IBMX | AKAP6 NPR2 TCIM RAPGEF4 ACE GFAP LPL CARD11 AVPI1 TNFAIP2 LRBA | 1.76e-04 | 368 | 180 | 11 | CID000003758 |
| Drug | Thioproperazine dimesylate [2347-80-0]; Up 200; 6.2uM; MCF7; HT_HG-U133A | 1.79e-04 | 197 | 180 | 8 | 6265_UP | |
| Drug | haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A | 1.79e-04 | 197 | 180 | 8 | 6960_DN | |
| Drug | Terbutaline hemisulfate [23031-32-5]; Down 200; 7.2uM; MCF7; HT_HG-U133A | 1.79e-04 | 197 | 180 | 8 | 6240_DN | |
| Drug | Nitrarine dihydrochloride [20069-05-0]; Up 200; 10.6uM; HL60; HT_HG-U133A | 1.79e-04 | 197 | 180 | 8 | 2188_UP | |
| Drug | Methapyrilene hydrochloride [135-23-9]; Up 200; 13.4uM; HL60; HG-U133A | 1.85e-04 | 198 | 180 | 8 | 1588_UP | |
| Drug | Proadifen hydrochloride [62-68-0]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 1.85e-04 | 198 | 180 | 8 | 3446_DN | |
| Drug | Naloxone hydrochloride [357-08-4]; Down 200; 11uM; MCF7; HT_HG-U133A | 1.85e-04 | 198 | 180 | 8 | 1506_DN | |
| Drug | Merbromin [129-16-8]; Up 200; 5uM; MCF7; HT_HG-U133A | 1.85e-04 | 198 | 180 | 8 | 3439_UP | |
| Drug | palmitoylacetylglycerol | 1.86e-04 | 3 | 180 | 2 | CID000146026 | |
| Drug | ZINC14806418 | 1.86e-04 | 3 | 180 | 2 | CID009847770 | |
| Drug | THIP Hydrochloride; Down 200; 22.6uM; MCF7; HT_HG-U133A | 1.92e-04 | 199 | 180 | 8 | 6511_DN | |
| Drug | Nizatidine [76963-41-2]; Up 200; 12uM; HL60; HT_HG-U133A | 1.92e-04 | 199 | 180 | 8 | 3047_UP | |
| Drug | Torsemide [56211-40-6]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 1.92e-04 | 199 | 180 | 8 | 5476_UP | |
| Drug | AC1MU1S9 | VGF NPR2 MYH7B CAPNS1 TCIM SNAP23 ORAI1 ACTL8 SATB1 LPL CARD11 TNFAIP2 LRBA DAGLA | 1.92e-04 | 572 | 180 | 14 | CID000003733 |
| Disease | Bipolar Disorder | VGF ANK3 NTRK1 NAPG GRM4 ACE GFAP ITIH1 NEFL TRANK1 SEC24C NR2E1 TIMELESS GNAL | 1.02e-06 | 477 | 174 | 14 | C0005586 |
| Disease | Neurodevelopmental Disorders | 1.36e-06 | 93 | 174 | 7 | C1535926 | |
| Disease | Intellectual Disability | AKAP6 TANC2 STAG1 NSF DOCK8 MCC NBEA CHD3 TRRAP ARL13B MACF1 DYNC1I2 ALG13 | 2.78e-06 | 447 | 174 | 13 | C3714756 |
| Disease | Lissencephaly | 3.98e-06 | 6 | 174 | 3 | C0266463 | |
| Disease | Seizures | 4.84e-05 | 218 | 174 | 8 | C0036572 | |
| Disease | Lymphoma | 9.04e-05 | 40 | 174 | 4 | C0024299 | |
| Disease | Epidermolysis bullosa with pyloric atresia | 1.03e-04 | 3 | 174 | 2 | C1856934 | |
| Disease | triacylglycerol 48:1 measurement | 1.29e-04 | 17 | 174 | 3 | EFO_0010404 | |
| Disease | visfatin measurement | 1.29e-04 | 17 | 174 | 3 | EFO_0801230 | |
| Disease | peripheral arterial disease, traffic air pollution measurement | 1.60e-04 | 194 | 174 | 7 | EFO_0004265, EFO_0007908 | |
| Disease | cholesteryl esters to total lipids in IDL percentage | 2.18e-04 | 50 | 174 | 4 | EFO_0022247 | |
| Disease | Schizophrenia | ANK3 NDE1 MAP6 NTRK1 GRM4 ACE TRRAP GFAP ITIH1 NEFL LPL MAD1L1 NR2E1 GNAL CGNL1 | 2.49e-04 | 883 | 174 | 15 | C0036341 |
| Disease | interleukin 1 receptor antagonist measurement | 2.73e-04 | 53 | 174 | 4 | EFO_0004754 | |
| Disease | nephrosis (biomarker_via_orthology) | 2.86e-04 | 22 | 174 | 3 | DOID:2527 (biomarker_via_orthology) | |
| Disease | Ovarian Serous Adenocarcinoma | 3.27e-04 | 23 | 174 | 3 | C1335177 | |
| Disease | urate measurement, bone density | AKAP6 PLB1 MCC LAMA5 RBCK1 MAP4K5 RBFOX1 ANKRD11 ROBO1 EIF2AK4 LRRFIP2 DNAH11 | 3.27e-04 | 619 | 174 | 12 | EFO_0003923, EFO_0004531 |
| Disease | Pachyonychia Congenita | 3.42e-04 | 5 | 174 | 2 | C0265334 | |
| Disease | Acute myelomonocytic leukemia | 3.42e-04 | 5 | 174 | 2 | C0023479 | |
| Disease | Pachygyria | 3.42e-04 | 5 | 174 | 2 | C0266483 | |
| Disease | Agyria | 3.42e-04 | 5 | 174 | 2 | C1879312 | |
| Disease | Progeria | 3.42e-04 | 5 | 174 | 2 | C0033300 | |
| Disease | calcium measurement | ATP6V1F ITIH1 KAT7 GRHL1 MAP4K5 CGN MACF1 C1QTNF4 EIF2AK4 CGNL1 PLEC GOLGB1 | 3.73e-04 | 628 | 174 | 12 | EFO_0004838 |
| Disease | cholesterol in chylomicrons and extremely large VLDL measurement | 4.40e-04 | 60 | 174 | 4 | EFO_0021898 | |
| Disease | cholesterol to total lipids in IDL percentage | 4.40e-04 | 60 | 174 | 4 | EFO_0022233 | |
| Disease | lysophosphatidylethanolamine 18:2 measurement | 4.74e-04 | 26 | 174 | 3 | EFO_0010369 | |
| Disease | Epilepsy | 4.79e-04 | 109 | 174 | 5 | C0014544 | |
| Disease | free cholesterol in chylomicrons and extremely large VLDL measurement | 4.99e-04 | 62 | 174 | 4 | EFO_0022263 | |
| Disease | bipolar disorder, schizophrenia, schizoaffective disorder | 5.11e-04 | 6 | 174 | 2 | EFO_0005411, MONDO_0004985, MONDO_0005090 | |
| Disease | Aplasia Cutis Congenita | 5.11e-04 | 6 | 174 | 2 | C0282160 | |
| Disease | triacylglycerol 50:1 measurement | 5.31e-04 | 27 | 174 | 3 | EFO_0010408 | |
| Disease | fish oil supplement exposure measurement, high density lipoprotein cholesterol measurement | 7.12e-04 | 7 | 174 | 2 | EFO_0004612, EFO_0600007 | |
| Disease | myoclonic-atonic epilepsy (implicated_via_orthology) | 7.12e-04 | 7 | 174 | 2 | DOID:0060475 (implicated_via_orthology) | |
| Disease | epidermolysis bullosa simplex (is_implicated_in) | 7.12e-04 | 7 | 174 | 2 | DOID:4644 (is_implicated_in) | |
| Disease | neuromyelitis optica (is_marker_for) | 7.12e-04 | 7 | 174 | 2 | DOID:8869 (is_marker_for) | |
| Disease | nephrosis (implicated_via_orthology) | 7.12e-04 | 7 | 174 | 2 | DOID:2527 (implicated_via_orthology) | |
| Disease | triacylglycerol 50:2 measurement | 8.02e-04 | 31 | 174 | 3 | EFO_0010409 | |
| Disease | Manic Disorder | 8.34e-04 | 71 | 174 | 4 | C0024713 | |
| Disease | sexual dimorphism measurement | FAM184B NYAP2 CDC42BPA KRT17 LRRC43 GRM4 ARHGEF40 TRANK1 CEP250 LPL ANKRD11 MACF1 CARD11 PLEC CROCC GCN1 | 8.90e-04 | 1106 | 174 | 16 | EFO_0021796 |
| Disease | HMG CoA reductase inhibitor use measurement | 9.26e-04 | 189 | 174 | 6 | EFO_0009932 | |
| Disease | triacylglycerol 51:2 measurement | 9.46e-04 | 8 | 174 | 2 | EFO_0021483 | |
| Disease | Sudden Cardiac Arrest | 9.46e-04 | 8 | 174 | 2 | C1720824 | |
| Disease | level of Triacylglycerol (53:4) in blood serum | 9.46e-04 | 8 | 174 | 2 | OBA_2045166 | |
| Disease | Sudden Cardiac Death | 9.46e-04 | 8 | 174 | 2 | C0085298 | |
| Disease | Autistic Disorder | 9.47e-04 | 261 | 174 | 7 | C0004352 | |
| Disease | body mass index, fasting blood insulin measurement | 9.65e-04 | 33 | 174 | 3 | EFO_0004340, EFO_0004466 | |
| Disease | free cholesterol to total lipids in large LDL percentage | 9.75e-04 | 74 | 174 | 4 | EFO_0022280 | |
| Disease | schizophrenia, intelligence, self reported educational attainment | 1.08e-03 | 346 | 174 | 8 | EFO_0004337, EFO_0004784, MONDO_0005090 | |
| Disease | Manic | 1.19e-03 | 78 | 174 | 4 | C0338831 | |
| Disease | monounsaturated fatty acids; 16:1, 18:1 measurement | 1.19e-03 | 78 | 174 | 4 | EFO_0022187 | |
| Disease | Lung diseases | 1.19e-03 | 78 | 174 | 4 | C0024115 | |
| Disease | angiotensin-converting enzyme measurement | 1.21e-03 | 9 | 174 | 2 | EFO_0006515 | |
| Disease | cathepsin F measurement | 1.21e-03 | 9 | 174 | 2 | EFO_0022038 | |
| Disease | triglyceride measurement, blood pressure | 1.21e-03 | 9 | 174 | 2 | EFO_0004325, EFO_0004530 | |
| Disease | Depression, Bipolar | 1.24e-03 | 79 | 174 | 4 | C0005587 | |
| Disease | Focal glomerulosclerosis | 1.25e-03 | 36 | 174 | 3 | C0017668 | |
| Disease | Epilepsy, Cryptogenic | 1.43e-03 | 82 | 174 | 4 | C0086237 | |
| Disease | Awakening Epilepsy | 1.43e-03 | 82 | 174 | 4 | C0751111 | |
| Disease | Aura | 1.43e-03 | 82 | 174 | 4 | C0236018 | |
| Disease | Creutzfeldt-Jakob disease (is_marker_for) | 1.51e-03 | 10 | 174 | 2 | DOID:11949 (is_marker_for) | |
| Disease | cystic kidney disease (implicated_via_orthology) | 1.51e-03 | 10 | 174 | 2 | DOID:2975 (implicated_via_orthology) | |
| Disease | arrhythmogenic right ventricular cardiomyopathy (is_implicated_in) | 1.51e-03 | 10 | 174 | 2 | DOID:0050431 (is_implicated_in) | |
| Disease | level of Triacylglycerol (51:3) in blood serum | 1.51e-03 | 10 | 174 | 2 | OBA_2045163 | |
| Disease | diacylglycerol 32.2 measurement | 1.51e-03 | 10 | 174 | 2 | EFO_0020055 | |
| Disease | bipolar I disorder | 1.53e-03 | 141 | 174 | 5 | EFO_0009963 | |
| Disease | degree of unsaturation measurement | 1.58e-03 | 39 | 174 | 3 | EFO_0022261 | |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.79e-03 | 215 | 174 | 6 | EFO_0008317, EFO_0008591 | |
| Disease | platelet component distribution width | NYAP2 STARD8 WAS DOCK8 LAMA5 IKZF1 LIN9 TRANK1 LPL MACF1 EIF2AK4 PLEC | 1.82e-03 | 755 | 174 | 12 | EFO_0007984 |
| Disease | Combined immunodeficiency | 1.82e-03 | 41 | 174 | 3 | C0494261 | |
| Disease | phosphatidylcholine 34:1 measurement | 1.84e-03 | 11 | 174 | 2 | EFO_0010375 | |
| Disease | diacylglycerol 34:3 measurement | 1.84e-03 | 11 | 174 | 2 | EFO_0020059 | |
| Disease | resting heart rate | 1.94e-03 | 149 | 174 | 5 | EFO_0004351 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 2.00e-03 | 150 | 174 | 5 | EFO_0004611, EFO_0020947 | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 2.01e-03 | 220 | 174 | 6 | EFO_0004529, EFO_0008317 | |
| Disease | triacylglycerol 56:6 measurement | 2.09e-03 | 43 | 174 | 3 | EFO_0010433 | |
| Disease | free cholesterol to total lipids in IDL percentage | 2.09e-03 | 43 | 174 | 3 | EFO_0022278 | |
| Disease | free cholesterol to total lipids in very small VLDL percentage | 2.09e-03 | 43 | 174 | 3 | EFO_0022290 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 2.10e-03 | 222 | 174 | 6 | EFO_0008317, EFO_0020943 | |
| Disease | level of Diacylglycerol (18:1_18:2) in blood serum | 2.19e-03 | 12 | 174 | 2 | OBA_2045171 | |
| Disease | level of Phosphatidylcholine (14:0_18:1) in blood serum | 2.19e-03 | 12 | 174 | 2 | OBA_2045062 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 2.25e-03 | 225 | 174 | 6 | EFO_0008317, EFO_0020947 | |
| Disease | cholesterol to total lipids in large VLDL percentage | 2.38e-03 | 45 | 174 | 3 | EFO_0022236 | |
| Disease | amino acid measurement | TANC2 MYH10 NYAP2 STAG1 CAPNS1 LRRK1 MCCC1 MAP3K4 GRHL1 MAP4K5 LRBA | 2.39e-03 | 678 | 174 | 11 | EFO_0005134 |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 2.44e-03 | 157 | 174 | 5 | DOID:224 (biomarker_via_orthology) | |
| Disease | mean fractional anisotropy measurement | 2.45e-03 | 95 | 174 | 4 | EFO_0008399 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 2.45e-03 | 229 | 174 | 6 | EFO_0004639, EFO_0008317 | |
| Disease | triacylglycerol 54:4 measurement | 2.54e-03 | 46 | 174 | 3 | EFO_0010422 | |
| Disease | Common variable immunodeficiency | 2.58e-03 | 13 | 174 | 2 | cv:C0009447 | |
| Disease | PR interval | 2.80e-03 | 495 | 174 | 9 | EFO_0004462 | |
| Disease | epilepsy (implicated_via_orthology) | 2.87e-03 | 163 | 174 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | Amyotrophic Lateral Sclerosis, Familial | 2.87e-03 | 48 | 174 | 3 | C4551993 | |
| Disease | Amyotrophic Lateral Sclerosis, Sporadic | 2.87e-03 | 48 | 174 | 3 | C1862941 | |
| Disease | atrial fibrillation (is_implicated_in) | 3.00e-03 | 14 | 174 | 2 | DOID:0060224 (is_implicated_in) | |
| Disease | triacylglycerol 46:2 measurement | 3.00e-03 | 14 | 174 | 2 | EFO_0010402 | |
| Disease | congenital hypothyroidism (implicated_via_orthology) | 3.00e-03 | 14 | 174 | 2 | DOID:0050328 (implicated_via_orthology) | |
| Disease | level of Phosphatidylethanolamine (18:2_0:0) in blood serum | 3.00e-03 | 14 | 174 | 2 | OBA_2045143 | |
| Disease | Left ventricular noncompaction | 3.00e-03 | 14 | 174 | 2 | C1960469 | |
| Disease | cholesteryl ester 20:3 measurement | 3.04e-03 | 49 | 174 | 3 | EFO_0010347 | |
| Disease | serum gamma-glutamyl transferase measurement | PLB1 NYAP2 CDC42BPA STAG1 MCC TRANK1 MAP4K5 ROBO1 TNFAIP2 CGNL1 LRBA GCN1 CDH6 | 3.11e-03 | 914 | 174 | 13 | EFO_0004532 |
| Disease | triglycerides to total lipids in medium LDL percentage | 3.22e-03 | 50 | 174 | 3 | EFO_0022334 | |
| Disease | polyunsaturated fatty acids to total fatty acids percentage | 3.22e-03 | 50 | 174 | 3 | EFO_0022303 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NEIEDTFRQFLNRDD | 46 | Q16864 | |
| DDDDFETNQLIDRNL | 316 | Q8NFU0 | |
| AVRFENFEDAALEEN | 161 | Q9Y2D0 | |
| AELEARLNLRDAEAN | 706 | Q7Z7A1 | |
| INQERAEELQEAERF | 1011 | Q7Z7A1 | |
| AEELQEAERFSRKAA | 1016 | Q7Z7A1 | |
| VRREDGIQAEASAND | 1036 | Q9NP73 | |
| AFSAEVQERLAQARE | 826 | Q8TER5 | |
| NEDTKFSLSDDQRDR | 826 | Q6UB99 | |
| EDVFEQTRVRFSDNA | 456 | Q9P2K8 | |
| TAENARRQEEAALLS | 76 | P12821 | |
| RRQEEAALLSQEFAE | 81 | P12821 | |
| ALDFRERQQSALDES | 221 | Q9H568 | |
| ARQQLEFEEAENSAL | 181 | Q9UKJ8 | |
| AAQRDAVDFDVRVDT | 1651 | Q9Y6D6 | |
| SNARAVIIFANEDDI | 276 | Q14833 | |
| VQDFNRTEFDRLNEI | 66 | Q6IC98 | |
| ALFQRSGDQLAEERA | 41 | Q5T686 | |
| RNRDEVQALAFDEQR | 96 | Q9BXJ3 | |
| NEEEAAARRARSFAQ | 41 | Q96DT5 | |
| EQLEAQEARAREAHA | 576 | Q5JTC6 | |
| ARDFDALNERIQKET | 191 | Q3SXY8 | |
| DNRTREQAQALREAF | 276 | P20594 | |
| VQAAAVRVSDRNFLD | 441 | Q9NVE4 | |
| ARIRAEVFNALDDDR | 26 | Q96NB1 | |
| LNRAEFEDQDDEARV | 861 | Q14692 | |
| QNQESELRAAFRVFD | 106 | Q8TD86 | |
| TNDDDIVFEDFARQR | 381 | P49407 | |
| AELETSEQVQRDFVR | 516 | Q9H5N1 | |
| ELAERLQREEEEAFA | 56 | Q9UJ41 | |
| SFRAEVRVFDINDNA | 116 | Q9Y5F3 | |
| QENFAEVARSRDVEV | 1361 | Q01484 | |
| REAATRDDDDDLLQF | 496 | Q86YJ7 | |
| RDDDDDLLQFAIQQS | 501 | Q86YJ7 | |
| VDREQIDFLAARQQF | 186 | Q8IVT2 | |
| LKEASESARQDFQRE | 546 | P04629 | |
| ESARQDFQREAELLT | 551 | P04629 | |
| QADSFIQDERLRIFA | 1386 | P52948 | |
| DLDLFRRAQARASED | 306 | O95251 | |
| VLQIDNARLAADDFR | 151 | P05783 | |
| DARDQNELLEFRNLE | 576 | Q96AA8 | |
| AVADNVERADALQLS | 41 | Q6NYC1 | |
| LLQIDNARLAADDFR | 221 | P13645 | |
| EFESRLADALQELRA | 236 | P02545 | |
| SRLFSDEDDRQINTR | 61 | Q5TKA1 | |
| TSARNYEREVDRNQE | 91 | Q9Y6D9 | |
| ALRDEEQRTQARAAA | 306 | Q96M61 | |
| AADALNRQIREEVAS | 281 | Q96JE9 | |
| QERGDQAFTEREAAE | 131 | Q16644 | |
| VNTANEAREVAFDLE | 76 | P19827 | |
| AEQQRRSRDDDVQYL | 856 | Q38SD2 | |
| EDLALRAQNDVAARQ | 416 | Q9BYM8 | |
| FLEETQQAQRAREVE | 841 | Q9ULE4 | |
| RTLAEINANRADAEE | 616 | Q13409 | |
| INANRADAEEEAATR | 621 | Q13409 | |
| TDRQFQELNELAEFA | 266 | Q96D31 | |
| EEDFQRALELSRQET | 226 | Q9H3M9 | |
| AAEREEALARQLDQA | 76 | A0A1B0GVG4 | |
| VREIAQDFNTDLRFQ | 71 | Q6NXT2 | |
| AAYDIEVNTRRAQAD | 221 | O75955 | |
| LQASLDAETRARNEA | 1646 | A7E2Y1 | |
| TELVEQAFRAIDRAD | 26 | Q9NV79 | |
| RAEDNADTLALVFEA | 91 | P12004 | |
| AAADQRRDFIDIESK | 26 | P06858 | |
| ARLDALDRLDAAAFQ | 61 | P53370 | |
| DALAQQAFEEARRRT | 136 | Q13951 | |
| NQSEEAVAAYRRALE | 536 | P50542 | |
| DNNEAAAADVLEFVR | 411 | P53618 | |
| RAEYEALAEQNRRDA | 261 | Q7Z3Y8 | |
| RAEYEALAEQNRRDA | 256 | Q7Z3Z0 | |
| NDLDQSQDEREVDFL | 386 | Q5VZ66 | |
| ANEAEFILSRQRAED | 1896 | P50851 | |
| SDSSRDRENQEEFLR | 376 | Q8NEV8 | |
| AAQARAEQLRDEARD | 1726 | P55268 | |
| DEEAQRASFLQNAVL | 641 | Q96CN5 | |
| FADAEEEQRRLGANS | 306 | P46459 | |
| LADENEFVRDTALRA | 1786 | Q92616 | |
| RNERLNGDETAVEDF | 141 | Q9Y4A0 | |
| EDFNIQLRRSQESAA | 116 | P98088 | |
| GAAFNLDTREDNVIR | 21 | P23229 | |
| SAEQEQRRRDAATAA | 666 | Q8TE49 | |
| TANSARLEVERDNLA | 131 | P14136 | |
| EALNRAVDATREAQE | 2386 | O15230 | |
| DLLRAASENSQDALR | 436 | Q13422 | |
| NILRDFRKEDDDQSE | 251 | Q9P242 | |
| RFSAEDEALSNIARE | 16 | Q9Y608 | |
| NRENLEQAFEVAERL | 251 | Q9UPN3 | |
| RFDFANLALAATQED | 116 | Q8TAX0 | |
| TADEDLVARVFRVQN | 1311 | Q92729 | |
| EDNNTNRLRESLDLF | 246 | P38405 | |
| RDDFSDADQLRVGND | 216 | Q9NV92 | |
| QREEAEAAARALARF | 191 | P12036 | |
| EAAARALARFAQEAE | 196 | P12036 | |
| ALARFAQEAEAARVD | 201 | P12036 | |
| EREFAIQSQITEAAR | 466 | Q9P2Q2 | |
| ENELAAEFTNAIRRE | 716 | P23508 | |
| AEREAQASLREQRAA | 976 | Q5TZA2 | |
| ERVVVFDRNLNTDQF | 181 | Q9NZI5 | |
| LLQIDNARLAADDFR | 156 | Q04695 | |
| AARRAAAALEEQLEA | 71 | Q96B18 | |
| NEEARRTNRQAELFA | 226 | Q8NF50 | |
| VSARRALENELEAAQ | 891 | Q0VF96 | |
| DNEAIARLLDRNQDA | 1256 | Q12873 | |
| SVDQVLRENAFLDRE | 51 | P0CW27 | |
| SAIARDLIDFDDRQQ | 2071 | P15924 | |
| EASESEEVRRFRQQF | 71 | Q96L46 | |
| EANESEEVRQFRRLF | 91 | P04632 | |
| DEAQRALAQRDQELE | 1806 | Q9BV73 | |
| ESLQRAEATNAELER | 226 | Q2TAC2 | |
| ERVLNASAEAQRAAA | 141 | Q8NI99 | |
| EFSSEEIREARQQAA | 1991 | Q12955 | |
| EQEFQEQLESARREA | 221 | Q96RQ3 | |
| QDSILFIREAQRADS | 106 | A2RUH7 | |
| FEEFLRENDQRSVDA | 161 | Q502W7 | |
| RNAVLDEANNDILAF | 251 | Q9Y4D2 | |
| RRDLDNAIEAVDEFA | 96 | Q9NR33 | |
| ARDNTDVRDFINQRL | 706 | P55285 | |
| EEFREGFDSDINNRL | 66 | Q8TE02 | |
| EFEIQDADIRRNTAS | 591 | Q92622 | |
| FQVENDQERFLSDLR | 726 | P53992 | |
| ERERDQAFHSRDEAQ | 376 | Q9BXL7 | |
| FAELENERDLQSRTE | 146 | Q9C0B2 | |
| LEEARASRDEIFAQS | 1661 | P35580 | |
| SNAEDSFLRELAIRN | 101 | Q8N309 | |
| RNARAERTASEINFD | 326 | Q9Y4K4 | |
| RSFRNAAAIAALQDE | 306 | Q9Y466 | |
| NVDVRFRSLAEESQA | 71 | Q96A99 | |
| EIEAARRQFQSQLAD | 581 | Q5BJF6 | |
| ENDRLASIAAELQFR | 1231 | Q9Y6R4 | |
| NFITRENLEARVEAA | 166 | Q9BYN8 | |
| EQAFRAAQEAVLLAA | 686 | Q5TD94 | |
| VTFENSADADRAREK | 161 | Q9NWB1 | |
| EDFNRILRDVEANTV | 451 | Q8WZA2 | |
| ADVLTRFENLAAEEA | 466 | Q7Z736 | |
| AEATRQAAAQEERLA | 311 | O15240 | |
| EAEEAERARQNALLF | 391 | O15240 | |
| ERARQNALLFAEEED | 396 | O15240 | |
| AQARRAQEEAEAEER | 581 | O15240 | |
| QAAQYTNAVRDRELD | 11 | P09661 | |
| LDQFDAIDFSDNEIR | 41 | P09661 | |
| SERNFQRLDFEELEE | 336 | Q5H9M0 | |
| VSDRFRDAAEELNAS | 471 | Q96D09 | |
| VANEAEFILNRQRAE | 1981 | Q8NFP9 | |
| RAQAQVEEAEELFRD | 221 | Q8TDN2 | |
| LEAAARNDLEEVRQF | 76 | Q96I34 | |
| ADTNRDRIDIANARA | 191 | O00161 | |
| RSSRQFAAALEDLNE | 1336 | Q9HCD6 | |
| EANTLFNEVSRAREA | 116 | Q9NXX6 | |
| ENSQELARLEAFSRA | 936 | Q6P1J6 | |
| EFFDEQVRSNNEAIR | 316 | Q7Z745 | |
| QTRTFFEDEQDDVRL | 1391 | Q7Z745 | |
| ANAVRQELDDAFRQI | 516 | Q5VT25 | |
| EENIQDLLRDAAERF | 821 | Q92502 | |
| DRIYQDERERSLNAA | 441 | Q01826 | |
| DEEDEVQRRAFLFLN | 416 | Q76KP1 | |
| ELALETRFNNRQDSD | 1986 | Q13023 | |
| ALQASQAERDTARLD | 921 | Q9P2M7 | |
| GDQLEAAARDTRDQF | 351 | Q15021 | |
| AAARDTRDQFLDTLQ | 356 | Q15021 | |
| LEEAEEESQRINANR | 1886 | P35749 | |
| RLAQERSADFAELEV | 241 | Q9UNS1 | |
| FLSEDDVVNKRNRAE | 106 | A0AVT1 | |
| ERLFGSLQEERAQDA | 511 | Q70EL4 | |
| AVVAEQEREDRQAAA | 156 | Q03169 | |
| AEEFRRQQADFVDLS | 366 | Q9NQW7 | |
| EARDRNIQESNFDRV | 181 | Q9Y3A6 | |
| ANVFENEERLRQAVE | 141 | Q99747 | |
| QLELDTVNAQADRAF | 236 | Q9H0U9 | |
| IQQAAERLERNFVDS | 1051 | Q5XPI4 | |
| DNDFTNERLTALQVR | 366 | Q14BN4 | |
| REVAEEAQAARLAAA | 196 | Q9BXM0 | |
| NASLEVAVLRDDFRQ | 156 | Q96MS0 | |
| AQDRARAEDLNSRVS | 166 | Q9Y3Q3 | |
| EERAQQEAEAAQRLA | 136 | Q99426 | |
| LNFADEDEAQAFRAL | 126 | P42768 | |
| REEAENTLQSFRQDV | 196 | P08670 | |
| FRQDVDNASLARLDL | 206 | P08670 | |
| FNRDQKADQDRLDLE | 396 | Q14683 | |
| IARSQLIDEFVDRFN | 656 | Q8WVM7 | |
| ASLEVAILRDDFRQN | 161 | Q9Y6N7 | |
| KRAVNSLRDFVDDDD | 36 | Q9H9C1 | |
| ELQALRARAEEAEAQ | 1611 | Q15149 | |
| EAERRAQQQAEAERA | 1746 | Q15149 | |
| EELARLQREAAAATQ | 1871 | Q15149 | |
| AARQRSQVEEELFSV | 2356 | Q15149 | |
| QLIDSANIRQEDAFD | 21 | Q9BZ95 | |
| EEAEDQANQTLARYR | 1046 | Q9H6N6 | |
| NLIRANESRLEEADQ | 536 | Q6ZXV5 | |
| NESRLEEADQLYRQA | 541 | Q6ZXV5 | |
| FENESARNRRESTDL | 2271 | O15050 | |
| ENTDQESLERLFRNS | 41 | Q9NR00 | |
| QAVRQFSIQAEDERE | 1361 | Q14669 | |
| RFDINDATGDLDANR | 3711 | Q9Y4A5 | |
| EEIRRLAADFQRAQF | 6 | O94874 | |
| ENFQEFIRQASEAEL | 786 | Q6EMB2 | |
| NEAAVRDISNDAVDI | 161 | Q8N402 | |
| EANEDLRRSFNALQE | 2581 | Q14789 | |
| RDQRVAAENALSVAE | 3161 | Q14789 | |
| EVEINRRTAAENEFV | 216 | Q14CN4 | |
| DFLRAQQETANAIRE | 261 | Q86VE0 | |
| RLNQAIERNAFLESE | 141 | Q9NXR1 | |
| QEIRDLRLAAEDATN | 141 | P07196 |